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Mycobacterium tuberculosis remains one of the world’s deadliest pathogens, and 
although decades of research have been dedicated to the discovery and development of 
anti-tuberculosis agents and vaccines, tuberculosis (TB) remains an ongoing global public 
health threat. Given the emergence of drug resistance and the poor treatment outcomes 
associated with this disease, it is imperative that we improve our understanding of the 
pathogenesis of M. tuberculosis in order to develop new anti-TB drugs and strategies for 
shortening drug treatment. Iron-sulphur (Fe-S) clusters are ubiquitous cofactors that are 
required for the maturation of various proteins, many of which are involved in essential 
biological processes. Multiprotein complexes are required for the in vivo assembly of Fe-S 
clusters, and the SUF system, encoded by the Rv1460-Rv1461-Rv1462-Rv1463-csd-Rv1465-
Rv1466 operon in M. tuberculosis, is thought to be the major Fe-S cluster biogenesis 
machinery in this organism. This process is poorly understood in mycobacteria, and it is 
currently unclear if proteins outside of this operon are involved in Fe-S cluster biogenesis. In 
this study, we sought to identify novel proteins involved in Fe-S cluster assembly in 
mycobacteria using various approaches. Initially we optimised blue-native PAGE for the 
analysis of mycobacterial cytoplasmic protein complexes, and demonstrated that protein 
complexes could be identified by immunodetection of BN-PAGE and subsequent gel fraction 
analysis by mass spectrometry. However, due to the complexity of the cytoplasmic fraction 
and poor resolution of this technique, we were unable to use it to identify complexes 
containing the Fe-S cluster biogenesis machinery. In a second approach, we set out to 
generate an antibody against Csd, an Fe-S cluster assembly protein, to facilitate 
immunodectection of the Fe-S cluster biogenesis machinery. However, heterologous 
expression of the M. tuberculosis Csd in Escherichia coli proved unsuccessful due to 
insolubility of the recombinant protein.  In an attempt to achieve soluble expression of Csd, 
a 6xHis-tag fusion was expressed in the closely related organism Mycobacterium smegmatis. 
Soluble expression of the fusion protein was optimised and confirmed by immunodetection.  
We then employed affinity enrichment using nickel-charged magnetic beads and mass 
spectrometry to identify potential interacting partners for Csd. Strains expressing a 6xHis-
tag SufC fusion and a 6xHis-tag mCherry fusion were also included for comparison. Utilising 
this method, we were able to demonstrate affinity enrichment for Fe-S cluster assembly 
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proteins, and Fe-S cluster-containing enzymes, as well as identify potential novel interacting 
partners. This work has established the methodology for identifying novel protein-protein 
interactions in mycobacteria, and lays the foundation for elucidating the process of Fe-S 
cluster assembly in mycobacteria. 
  




Mycobacterium tuberculosis is nog steeds een van die mensdom se dodelikste 
patogene ten spyte van intensiewe navorsing wat fokus op die ontdekking en ontwikkeling 
van antimikrobiese middels en vaksiene om tuberkulose (TB) te bekamp.  Die toename in 
antimikrobiese weerstandbiedendheid in hierdie patogeen sowel as die onbereidwilligheid 
van pasiënte om die streng medisynekursus te volg, beklemtoon die noodsaaklikheid om die 
organisme en sy oorlewingsmeganismes beter te verstaan.  Dit kan lei tot die ontwikkeling 
van nuwe teen-TB middels en die verkorting van middelbehandeling. Yster-swawel (Fe-S) 
komplekse dien as kofaktore vir verskeie proteïene, waarvan baie noodsaaklike rolle verig in 
sekere biologiese prosesse. Multiproteïen komplekse is nodig sodat Fe-S komplekse in vivo 
gesintetiseer kan word – ‘n proses wat nog nie goed beskryf is vir mikobakterieë nie. Die 
SUF sisteem, wat in M. tuberculosis deur die geenoperon Rv1460-Rv1461-Rv1462-Rv1463-
csd-Rv1465-Rv1466 geënkodeer word, word beskou as die hoofkomponent in die biogenese 
van Fe-S komplekse. Onsekerheid heers of ander proteïene buite dié van die operon ook ‘n 
rol speel in biogenese. In hierdie studie het ons gepoog om nuwe proteïene te identifiseer 
wat betrokke kan wees in die biogenese van Fe-S komplekse deur verskeie benaderings te 
volg.  Aanvanklik het ons die tegniek van blou-natuurlike poliakrielamied jelelektroforese 
(blue-native PAGE) geöptimiseer om mikobakteriële sitoplamiese proteïenkomplekse te 
analiseer. Ons het daarmee geslaag om proteïenkomplekse te identifiseer met behulp van 
immuno-opsporing gevolg deur jelfraksie-analise met massa-spektrometrie. Vanweë die 
kompleksiteit van die sitoplasmiese fraksie en die swak resolusie van die tegniek is geen 
komplekse wat Fe-S komplekse bevat, geïdentifiseer nie. In die tweede benadering is daar 
gepoog om ‘n teenliggaam te genereer vir Csd, ‘n proteïen betrokke in die biogenese van Fe-
S komplekse. Dit is ten doel om die immuno-opsporing van die Fe-S komplekse te 
vergemaklik. Heteroloë uitdrukking van Csd in E. coli het gelei tot die produksie van ‘n 
onoplosbare proteïen. Deur die proteïen uit te druk in die nabyverwante M. smegmatis, 
tesame met ‘n 6xHis fusie, het gelei tot ‘n oplosbare produk wat later bevestig is deur 
immuno-opsporing. Ons het daarna affiniteit-verryking gebruik met behulp van nikkel-
gelaaide magnetiese krale en massa-spektrometrie om proteïene wat moontlike interaksies 
met Csd het, te identifiseer. Die nodige kontroles (rasse wat ‘n 6xHis fusie het met 
onderskeidelik ‘n sufc en ‘n mcherry geen) is ingesluit ter vergelyking. Met die gebruik van 
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hierdie metode het ons affiniteit-verryking vir proteïene betrokke in die biogenese van Fe-S 
komplekse gewys asook Fe-S kompleksbevattende ensieme. Ons het terselfdetyd nuwe 
potensiële proteïene geïdentifiseer wat interaksie toon met Fe-S komplekse. Hierdie studie 
het ‘n metode daargestel vir die identifikasie van nuwe proteïen-proteïen interaksies in 
mikobakterieë en lê ‘n fondasie vir die toeligting van die proses van die biogenese van Fe-S 
komplekse in mikobakterieë. 
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Chapter 1: Literature review 
The investigation of protein-protein interactions in mycobacteria 
1.1. Introduction 
Mycobacterium tuberculosis, the causative agent of tuberculosis (TB), remains one of 
the leading causes of death worldwide, claiming the lives of approximately 2 million people 
annually1. M. tuberculosis was first identified in 1882 by Robert Koch, and has since claimed 
the lives of thousands2. Despite decades of research aimed at the development of anti-TB 
drugs and vaccines, TB remains a global health threat. Upon initial M. tuberculosis infection, 
most people are able to contain the infection, leading to the development of a latent 
infection. Latent TB is defined as a persistent immune response to M. tuberculosis in the 
absence of clinical symptoms of disease, and is estimated to affect one third of the world’s 
population3. This colossal reservoir of potential active TB patients makes this disease 
particularly challenging to contain. Reactivation of latent M. tuberculosis infection occurs in 
approximately 10% of infected individuals. An estimated 9 million new infections occur each 
year, and in sub-Saharan Africa the risk of progression to active disease is greatly increased 
due to HIV-TB co-infection, where the prevalence is highest. Given the increase in drug 
resistance and the poor adherence of TB patients to a lengthy and arduous anti-TB drug 
regimen, it is critical to investigate the virulence pathways of M. tuberculosis and find new 
ways to treat this devastating disease4. 
In recent years, exploring protein-protein interactions (PPIs) has become a popular 
approach for elucidating bacterial physiology and pathogenesis. Here we review current PPI 
detection techniques, with a focus on methods applied in mycobacteria for both initial 
identification of PPIs and the validation thereof. We also discuss high-throughput PPI 
detection methods and databases used to build and catalogue interaction networks. 
1.2. Defining protein-protein interactions 
Proteins are large macromolecules consisting of specific amino acid chains necessary 
for the cellular function of all living organisms, and have diverse roles within the cell. These 
functions include gene regulation, catalysis of chemical reactions, mediation of the immune 
response, involvement in signalling cascades, and maintaining the structural stability of the 
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cell5. Studying cellular processes on a protein level is crucial for understanding the 
physiology and pathogenesis of bacteria6. In the pre-genomic era, molecular biologists 
established the central dogma which described the flow of genetic information from DNA to 
protein. Genes and proteins were largely studied on an individual level, giving very little 
insight into how these cellular processes occur spatially and over time. In the post-genomic 
era, high-throughput techniques have provided an abundance of transcriptomic and 
proteomic data, giving us a more holistic view of cellular metabolism and allowing us to 
define the relationship between proteins and genes within a given pathway or complex7,8. 
PPI studies are a recent focus in protein biochemistry. The identification of these 
interactions and mapping thereof to pathways and complexes have led to the design of PPI 
networks which all contribute to the construction of the interactome9. 
Proteins rarely function in isolation, but rather rely on interactions with other 
proteins for their function. This interaction is defined as two proteins coming into contact 
via a specific docking mechanism to perform a function within the cell that may be distinct 
from the independent function of these proteins10. These interactions are either homo-
dimeric, when two copies of the same protein interact, or hetero-dimeric, when two 
different proteins interact. Proteins can also interact as part of higher order complexes, 
where more than two proteins interact within a complex or pathway to achieve a singular 
outcome. Permanent interactions are defined as stable, whereas fleeting interactions are 
defined as transient11. Transient interactions are typically involved in signalling cascades 
whereas stable interactions are found predominantly in the main cellular machinery such as 
enzymatic complexes and ribosomal subunits12. Although proteins bind with varying 
affinities, interacting proteins bind at their interface via complementary docking sites with 
extreme specificity, a direct result of their physicochemical properties. These properties 
include covalent bonds, hydrogen bonds, hydrophobic bonds, ionic interactions and Van der 
Waals forces13. Binding domains associated with PPIs are highly conserved between species 
and throughout evolution14. 
Proteins can also be involved in multiple interactions, adding a level of complexity to 
bacterial physiology that cannot be predicted by genome sequence analysis15. PPIs can 
occur concurrently or consecutively depending on the cellular environment and demand at 
any point in time. These interactions are tightly regulated within the cell to ensure cellular 
Stellenbosch University  https://scholar.sun.ac.za
3 
 
survival and maintain homeostasis. The frequency of PPIs are influenced by a number of 
factors including perturbations in cellular homeostasis caused by environmental stressors 
and changes in protein concentrations13. Previous computational analyses of PPIs have 
shown that interactions between proteins which are situated adjacent to each other in the 
genome and are involved in metabolism and regulation occur most frequently12. 
1.3. Methods for studying protein-protein interactions and their application in 
mycobacteria  
Two groups of techniques are generally employed for the detection of PPIs, namely, 
binary and co-complex techniques. Binary techniques are used to specifically determine 
whether two proteins interact, whereas co-complex methods are commonly used to identify 
two or more interacting partners10.  
1.3.1. Binary techniques  
1.3.1.1. Yeast two-hybrid 
Yeast two-hybrid (Y2H) is a technique used for detecting binary PPIs and was 
developed in 1989 for application in yeast cells16.  A bait protein is expressed as a fusion 
with the DNA-binding domain and an individual protein or libraries of prey proteins are 
expressed as fusions with the activation domain of a site-specific transcription factor. If the 
bait and prey proteins interact, the DNA-binding domain and activation domain are brought 
into close enough proximity for the transcription factor to be reconstituted. This in turn 
permits the expression of downstream reporter genes and results in growth on selective 
media or a colour reaction. Once the bait and prey fusion proteins are expressed in the 
cytosol, they must be able to translocate into the nucleus so that activation of transcription 
can occur. One of the major limitations is the high frequency of false positives associated 
with the Y2H system, with an estimated 50% inaccuracy17. Y2H is not suitable for detecting 
interactions involving more than two proteins or those dependent on post-translational 
modifications18.  In addition, Y2H cannot be used to study membrane proteins, transcription 
factors, PPI kinetics or strongly acidic proteins19. Y2H may also not be suitable for 
interactions which only occur under certain conditions, such as oxidative stress. An example 
of this is the phosphorylation dependent FtsZ-FipA interaction in M. tuberculosis which 
occurs during cell division under oxidative stress conditions, which could not be confirmed 
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by Y2H20. However, due to the limited number of feasible alternatives, Y2H remains the 
most commonly used technique for detecting PPIs. To overcome this limitation, Y2H is used 
in conjunction with other methods for detecting PPIs in order to validate Y2H interactions.  
The use of Y2H for the study of PPIs was originally proposed by Fields and Song, who 
later proved this concept by demonstrating the interaction between SNF1 and SNF416. The 
principle of Y2H was confirmed by Ma and Ptashne using two known interacting proteins, 
GAL4 and GAL80, which is an inhibitor of GAL4. They showed that fusing GAL80 to an 
activation domain facilitated the initiation of transcription in the presence of GAL4 fused to 
the GAL80 DNA binding domain21. In the late 1990s, Y2H played a significant role in 
validating protein interactions involved in bacterial cell division, especially those involved in 
Z-ring formation. FtsZ, a tubulin homolog, has been shown to interact with FtsA, an actin 
homolog in Bacillus subtilis22, Caulobacter crescentus23, Escherichia coli and Staphylococcus 
aureus24. The E. coli FtsZ has also been shown to interact with the B. subtilis FtsA, indicating 
evolutionary conservation of the domains responsible for interaction. These domains could 
provide valuable information about bacterial pathogenicity and could serve as potential 
antimicrobial drug targets24.  
The application of Y2H in mycobacteria dates back to the year 2000, where it was 
used to show interaction between the M. tuberculosis single-stranded DNA binding protein, 
MtuSSB, and its E. coli homolog, EcoSSB. These proteins were shown to be capable of 
heterooligomerization25. The following year, Y2H was employed to investigate the 
interacting partners of the 4.2 domain of RpoV26. The principle sigma factor, RpoV, was 
previously shown to restore virulence to an attenuated Mycobacterium bovis strain 
containing a point mutation in the 4.2 domain of RpoV27. In this study, WhiB3 was shown to 
interact with the 4.2 domain of RpoV in virulent strains but not with the mutated domain. 
WhiB3 was proposed to be involved in regulating the transcription of genes that affect the 
host immune response26. WhiB3 was later characterised as a core transcriptional regulator 
in M. tuberculosis which contributes to the maintenance of redox homeostasis and the 
virulence of M. tuberculosis28,29. 
One of the most significant contributions of Y2H to our knowledge of how M. 
tuberculosis evades the host immune response is the discovery of the secretion in 
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mycobacteria (Snm) pathway required for the secretion of ESAT-6 and CFP-10, two key T-cell 
antigens. Snm mutants were unable to replicate inside the host macrophage and was unable 
to inhibit macrophage inflammatory response30. Y2H can also be used to screen for 
antimicrobial agents. Y2H was employed in 2012 to screen for small molecules that inhibit 
the interaction between mycobacterial L12 and L10, two ribosomal proteins. The study was 
aimed at identifying anti-TB compounds that could target ribosomal protein interaction31. 
Interaction between Mycobacterium fluoroquinolone resistance protein A (MfpA) and 
Mycobacterium fluoroquinolone resistance protein B (MfpB) was identified using both Y2H 
and a protein complementation assay (discussed later). MfpB was previously unknown, and 
its interaction with MfpA is implicated in protecting DNA gyrase against antibiotics targeting 
it, such as fluoroquinolone32. 
An example of using Y2H to study the proteins involved in a biosynthetic pathway is 
its application to studying iron-sulphur (Fe-S) cluster biogenesis in mycobacteria. Y2H was 
used in 2005 to identify interactions between the sulphur mobilisation (SUF) machinery in 
M. tuberculosis, the only Fe-S cluster biogenesis system identified in this organism33. 
Furthermore, in 2006, Y2H was used to show that SufB, an essential protein in the SUF 
system34,35, requires protein splicing for its function, suggesting that the inhibition of protein 
splicing could be a potential target for anti-TB drugs36. Moreover, in 2014, the interaction 
network of IScSMtb, one of three cysteine desulphurases in M. tuberculosis33,37–41, was 
identified using both Y2H and pull-down assays, and a novel mechanism of sulphur transfer 
by direct interaction with Fe-S cluster-dependent enzymes38.  
1.3.1.2. Protein complementation and biomolecular fluorescence 
Protein complementation assays (PCAs) are based on the concept of splitting a 
reporter protein in two and fusing each end to two potential interacting proteins, one 
fragment fused to the bait protein and the other fused to the prey protein42. When the bait 
and prey proteins come into close enough proximity to each other, the fragmented reporter 
protein is reconstituted, thereby regaining its activity. The original reporter for PCA was 
dihydrofolate reductase (DHFR)43. Over the years many variations of PCAs have been 
developed. One such modified PCA is the bacterial adenylate cyclase-based 2-hybrid system 
(BACTH). Reconstituted adenylate cyclase of Bordetella pertussis regains activity thereby 
converting ATP to cAMP, initiating transcription of downstream reporter proteins. Due to 
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the nature of this system, the frequency of false results is low44. BACTH has been used to 
confirm the interaction between FtsZ, involved in Z-ring formation at the start of cell 
division, and ClpX, a potential cell division regulator45.  
Mycobacterial protein fragment complementation (M-PFC) is a variation of PCA 
involving the heterologous expression of split mammalian DHFR in mycobacterial cells. 
Mammalian DHFR has a lower affinity than bacterial DHFR to the trimethoprim inhibitor, 
which allows for selection of bacteria containing positive PPIs in the presence of 
concentrations of trimethoprim that inhibit the bacterial DHFR but not the mammalian 
DHFR46. This system was used to confirm interactions between secreted antigens ESAT-6 
and CFP-10. Similarly, M-PFC was also used to confirm PPI in tryptophan (Trp) auxotrophic 
M. smegmatis and E. coli between ESAT-6 and CFP-10, amongst others. Here the reporter 
protein was Trp1 of S. cerevisiae, involved in Trp biosynthesis47. Reconstitution of Trp1 upon 
PPI resulted in growth of bacterial cells on Trp-deficient media48. M-PFC has also recently 
been used on a high-throughput scale to identify small molecule inhibitors of PPIs in 
mycobacteria49.  
Other variants of PCAs include bimolecular fluorescence complementation (BiFC) 
and bimolecular luminescence complementation (BiLC) which uses fluorescent proteins and 
luminescent proteins as reporters, respectively. A positive PPI results in the reconstitution 
of two non-florescent/luminescent reporter protein components, and generates a 
measurable fluorescent50 or luminescent51 signal. A major advantage of BiFC and BiLC is the 
ability to detect PPI in vivo, in real-time. In addition, the strength of the interaction may also 
be related to the fluorescent or luminescence intensity. BiFC has recently been employed in 
E. coli, together with BACTH and other in vitro techniques, to show interaction between 
dimethyl sulfoxide subunit D (DmsD), a twin-arginine translocation (Tat) pathway-specific 
chaperone implicated in the maturation of oxidoreductases, and general chaperones as well 
as proteins involved in molybdenum cofactor biogenesis. These results point toward DmsD 
acting as a node while ushering its substrate through a cascade of chaperone-mediated 
events associated with the maturation of protein folding52. BiFC has also been used to 
investigate PPIs involved in protein folding and export in the Tat pathway of Gram-negative 
and Gram-positive bacteria53. BiFC and BiLC have, to date, not been applied in mycobacteria 
for the detection of PPIs. 
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1.3.1.3. Fluorescence and bioluminescence resonance energy transfer 
Resonance energy transfer is based on the principle of energy transfer between two 
molecules. Fluorescent resonance energy transfer (FRET) and Bioluminescence resonance 
energy transfer (BRET) can be used to study PPIs in vivo, in real time.  
FRET utilizes a donor and acceptor fluorescent protein with overlapping excitation 
and emission spectra that are expressed as fusions with two possible interacting partners. 
Yellow fluorescent protein (YFP) and cyan fluorescent protein (CFP), derivatives of green 
fluorescent protein, are generally used as reporters during FRET. When interaction does not 
occur, the emission spectrum is represented solely by that of the donor fluorescent protein. 
When interaction does occur, the acceptor fluorescent protein is excited, thereby emitting 
at a distinguishable wavelength. Cells expressing fluorescent proteins can be analysed using 
a confocal microscope or fluorometry. In 2012, a single-cell FRET-based method was 
employed to track translocation of M. tuberculosis and Mycobacterium marinum into the 
host macrophage cytosol to monitor phagolysosomal rupture. Furthermore, M. tuberculosis 
and M. marinum strains lacking the secreted antigen associated with membrane rupture, 
ESX-1 secreted protein ESAT-6, did not display translocation to the cytosol or 
phagolysosomal rupture, but was restored upon complementation of the ESX-1 secretion 
system. It was observed that phagolysosomal rupture was followed by necrotic cell death of 
host macrophages. This study suggests a novel mechanism of M. tuberculosis and M. 
marinum to evade the host innate immune response by cytotoxicity, enabling the spread of 
virulent mycobacteria to new host cells54. 
BRET is superior to FRET due to the fact that an external source of light is not 
required for excitation of the donor protein, and background due to auto-fluorescence is 
significantly reduced. The bait protein is expressed as a fusion with luciferase, a 
bioluminescent enzyme, from Renilla reniformis, an anthozoan coelenterate. Luciferase 
activity on the coelenterazine substrate results in the emission of blue light at 475 nm which 
overlaps with the excitation spectrum of the acceptor protein, YFP, fused to the prey 
protein. In the absence of interaction, blue light from the donor is emitted at 475 nm. When 
interaction does occur, luciferase transfers energy to YFP, resulting in yellow light emitted at 
527 nm. BRET has been used in cyanobacteria to identify interactions between circadian 
clock proteins55. BRET is used predominantly in eukaryotes instead of bacteria, most likely 
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due to the decreased sensitivity resulting from poor expression of the eukaryotic luciferase. 
It was however modified in 2014 to use a bacterial luciferase, LuxAB from Photorhabdus 
luminescens, to facilitate energy transfer to eYFP. Multiple interactions were identified using 
this technique, confirming its usefulness in investigating PPIs in bacteria56. To date, this 
technique has not been applied in mycobacteria.    
1.3.2. Co-complex techniques 
1.3.2.3. Co-immunoprecipitation and affinity purification 
Co-immunoprecipitation (CoIP) and affinity purification (pull-down assays) are co-
complex techniques that are used for identifying interactions between two or more 
proteins, based on the affinity of one protein for another protein in the complex10. Affinity 
purification techniques can be used to confirm interactions identified by binary techniques 
or to identify interactions that occur natively within the cell. CoIP is used when an antibody 
generated against the bait protein is available. In the absence of an antibody, an affinity 
purification can be used which is based on cloning a fusion tag in frame with the bait protein 
and using the appropriate agarose resin for purification. 
CoIP has been used to confirm interactions between Lsr2, a global gene regulator, 
and MSMEG_4334, a M. smegmatis hypothetical flavoprotein involved in bacterial 
resistance to oxidative stress. This interaction was originally identified using bacterial 2-
hybrid and pull-down assays57. In 2004, CoIP was successful in identifying both homotypic 
and heterotypic interactions between the known proteins of the fatty acid synthase-II (FAS-
II) complex responsible for mycolic acid biogenesis, essential for the survival of M. 
tuberculosis58. Later, in 2005, CoIP was again used by the same research team to identify 
accessory interacting partners of the FAS-II complex. This study suggests that one of the 
identified interaction, KasB-Pks13, could be targeted as an alternative for peptidomimetic 
antibiotics59. In 2010, CoIP was used to confirm interactions between a MazF protein, 
Rv1495, believed to play a role in dormancy in M. tuberculosis, and MtbTopA, the only DNA 
topoisomerase I in mycobacteria. This study suggests a novel mechanism of bacterial 
survival by the regulation of MtbTopA by MazF. 
Recently a one-step affinity purification method was developed for the identification 
of PPIs in mycobacteria. Four epitopes were investigated for the isolation of protein 
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complexes, namely enhanced green fluorescent protein (eGFP), FLAG, protein A and 
haemagglutinin. Of the four epitopes tested, eGFP proved to be the most suitable candidate 
due to its cost-effective purification and relatively low background as determined by high-
resolution mass spectrometry and proteomic data analysis. The fluorescent nature of eGFP 
makes it easy to measure expression and is convenient when determining subcellular 
localization. In this study, RNA polymerase subunit A was used as bait for the co-purification 
of other members of the RNA polymerase complex60. 
In 2010, Bolstad and Wood combined trichloroacetic acid crosslinking and affinity 
purification to characterize PPIs within sulphur trafficking systems of E. coli. Using this 
technique, PPIs that form part of the SUF system were identified. In E. coli the SUF system is 
responsible for synthesizing Fe-S clusters under oxidative stress and iron limitation61–65. This 
method was used to confirm a SufE-SufS and SufE-SufB interaction previously identified in in 
vitro studies, and  identified interactions between SufE and other Fe-S cluster proteins that 
may play an important role in Fe-S cluster assembly66.  
A major limitation of using affinity purification to study PPIs in mycobacteria is the  
problem of misfolding and aggregation associated with heterologous expression of 
mycobacterial proteins  in E. coli, 67. To overcome this problem, Arbing et al investigated the 
use of a maltose binding protein fusion tag to increase protein solubility68. Six Esx protein 
complexes were expressed and purified using a pull-down assay and the crystal structures 
were determined. This strategy resulted in a significant increase in the proportion of soluble 
protein, suggesting that this method may also be useful for affinity purification of 
mycobacterial complexes69.  
Co-complex techniques are limited by the need for in vitro manipulation of protein 
lysates. Other limitations include a bias towards interactions which occur with the strongest 
affinity, resulting in the loss of transient interactions. Co-complex methods also have limited 
sensitivity with a high frequency of non-specific interactions70.  
1.3.3. Building interaction networks  
Two main techniques are used for high-throughput analysis of PPIs, namely, 
modified two-hybrid systems and affinity purification followed by mass-spectrometry71. 
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Before the development of these techniques, computational predictions tools were used, 
and continue to play a valuable role in PPI studies. 
1.3.3.1. Computational prediction of PPI 
Historically, computational PPI predictions were largely based on subunit interface 
information obtained from protein structure databases72. A major advancement in 
computational predictions was the availability of whole genome data which allowed 
predictions to be made based on genome sequence data73. Information such as gene 
fusions74,75, gene co-occurrence76 and conserved gene order77,78 were used to predict PPIs. 
Computational tools including, but not limited to, data mining and machine learning, 
homology based approaches, structure, domain and motif based approaches have been 
used to predict various interaction networks as well as host-pathogen PPIs79. Computational 
tools have been used previously in an attempt to predict and construct the interactome of 
M. tuberculosis80,81. This is a challenging task given that approximately one third of the open 
reading frames encoded by the M. tuberculosis genome consist of proteins of unknown 
function. It is for this reason that current PPI data generated using computational tools and 
homology protein mapping have only covered a fraction of the M. tuberculosis genome82. 
1.3.3.2. High-throughput two-hybrid techniques 
PPIs are critical during processes such as protein secretion and signal transduction83. 
However, very little PPI data is available for commonly used model organisms and even 
fewer with global interaction networks. High-throughput screens have been used in recent 
years to generate large PPI datasets. Y2H is one of the few PPI techniques that have 
successfully been used on a large scale. This is typically achieved by expressing the desired 
bait protein as a DNA-binding domain fusion and creating a cDNA or domain library which is 
then fused to an activation domain for screening84. The majority of PPI data has been 
generated using a modified Y2H method, and this data has been used largely to generate 
interaction networks for various species85, including E. coli86, Helicobacter pilori87, 
Saccharomyces cerevisiae88–90 and Drosophila melanogaster91, to name a few. Recently, a 
binary PPI interaction network map has been generated for E. coli using only Y2H and covers 
approximately 70% of the E. coli proteome92. In 2008, an interaction network map was 
generated for S. cerevisiae by combining data generated using both binary and co-complex 
techniques as well as curated from literature93. High-throughput Y2H was also recently 
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applied to investigate interactions between secreted M. tuberculosis proteins and those of 
the host macrophage. EsxH, in complex with EsxG, was found to disrupt the function of the 
host endosomal sorting complex required for transport. This plays a role in facilitating 
lysosomal degradation by direct interaction with the human hepatocyte growth factor-
regulated tyrosine kinase substrate. These findings provide insight into the mechanisms 
employed by M. tuberculosis to evade the host immune response94. 
A significant amount of M. tuberculosis H37Rv PPI data was generated in 2010 when 
the first global interaction network was constructed for this organism using a high-
throughput bacterial two-hybrid technique. Over 8000 interactions were identified and 
validation using affinity purification revealed a success rate of over 60%. Ninety-four 
conserved complexes were identified using cross-species analysis between M. tuberculosis 
networks and those of other prokaryotes. This global PPI network also enabled the authors 
to determine an association between sub-networks and protein secretion pathways. An 
example of these sub-networks is the interaction between two WhiB-like core regulators, 
namely WhiB3 and WhiB7, proposed to play a role in regulating persistent infection. Protein 
function predictions of many hypothetical proteins were made using this PPI data and 
pathway mapping tools83.  
Many high-throughput PPI studies, predominantly based on a modified Y2H method, 
have been cross-compared to obtain a more comprehensive and high quality binary 
interaction network92,95. These combined datasets often give a clearer picture of interaction 
networks by giving higher confidence in interactions identified. These interaction networks, 
however, do not represent all possible interactions that could be identified using Y2H, partly 
due to the difficulty in using library screening methods to sample all possible combinations 
of PPIs84. The main disadvantage of high-throughput screens is the high frequency of false 
positives and negatives96. This problem can be resolved by using bioinformatics tools to 
compare interaction data of the organism of interest and selecting those interactions that 
occur in multiple datasets97. High-throughput PPI data is generally of lower quality than PPI 
data generated using small scale PPI techniques. It is therefore important that high-
throughput PPI data be validated using other low-throughput binary methods to surmount 
the problems of inaccuracy associated with high-throughput techniques and those inherent 
to Y2H. 
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1.3.4. Affinity purification – mass spectrometry 
This technique is based on CoIP or affinity purification, as described above, to enrich 
for protein complexes of interest and subsequent identification of interacting partners by 
mass spectrometry98. High-throughput affinity purification followed by mass spectrometry 
(AP-MS) has been used on a large scale to identify protein complexes in organisms such as E. 
coli99,100 and S. cerevisiae101–104. Although AP-MS allows us to identify proteins that form 
part of the same complex, it gives little information about the direct binary interactions 
between proteins within the complex. Binary PPI techniques  are therefore still required to 
confirm interactions identified by AP-MS and together, elucidate protein complex 
topology92,95.  
AP-MS has vastly increased the possibilities for PPI studies. AP-MS can be used to 
analyse post-translational modifications, stoichiometry, protein abundance and structural 
organisation. This technique has been enhanced by various cross-linking techniques, aimed 
at preserving PPIs in their physiologically relevant state105. In 2014, an in vivo formaldehyde 
cross-linking system was developed for the identification of mycobacterial protein 
complexes using AP-MS106. Cross-linking followed by MS provides a new avenue for protein 
modelling by mapping structural details of physiologically relevant protein complexes. 
Although this is a fairly new and still challenging area of protein biochemistry, it holds great 
promise for the advancement of structural biology and the understanding of interaction 
network topology107. 
1.3.5. PPI databases 
Storing high-throughput interaction data in publicly accessible PPI databases is an 
important factor in interactome studies. Several PPI databases exist that are either specific 
for one organism or many organisms within a certain phylogenetic group. Bacteriome.org is 
an example of a PPI database designed specifically for E. coli, and currently reports 7613 
interactions between 2283 proteins when using a combined dataset108. Datasets are often 
graphically represented, where proteins are represented as nodes and interactions between 
proteins represented by a line which connects them in a “ball-and-stick” fashion. This 
technique is easily applied to binary PPI datasets, but can be challenging for AP-MS datasets, 
where direct interactions within complexes are unknown. AP-MS datasets are then 
represented using a matrix or spokes model109.   
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The majority of data found on PPI databases are curated from published literature, 
and usually mention the PPI detection method used and the reference to the article that 
published it. Databases are represented in various ways depending on the detection method 
used and the preferences of the designers. It is for this reason that the International 
Molecular Exchange (IMEx) consortium was developed; a platform comprised of a number 
of publicly available interaction databases that have developed a partnership to generate a 
non-redundant PPI dataset that adheres to the XML-based proteomics standard, named the 
proteomics standard initiative – molecular interactions (PSI-MI)110,111. A limited number of 
PPI databases are available for bacteria. One of the participating partners in the IMEx 
consortium is the IntAct molecular interaction database which is currently the most 
comprehensive database available, reporting over 294 000 interactions for over 100 
organisms, including Homo sapiens and various bacterial species112. The microbial protein 
interaction database (MPIDB) provides PPI information for various microbial species, and 
currently boasts 24 295 experimentally determined interactions between 250 bacterial 
species, including mycobacteria113. MPI-LIT is a database comprised entirely from microbial 
PPI data curated from the literature and links 940 proteins by 746 binary interactions97. 
Another PPI database is STRING, which combines known and predicted interactions 
representing physical and functional associations. STRING has recently released its tenth 
version which covers over 2000 organisms114. Other databases to consider are: the Database 
of Interacting Proteins (DIP)115, the Molecular INTeraction database (MINT)116, the Biological 
General Repository for Interaction Datasets (BioGRID)117, the Biomolecular Interaction 
Network Database (BIND)118 and the Pathosystems Resource Integration Center (PATRIC)119. 
1.4. Concluding remarks 
In recent years, high-throughput PPI studies have generated a large amount of data 
available in publicly accessible databases that have contributed significantly to our 
understanding of dynamic biological interactions and their effect on cellular physiology. PPI 
databases for specific organisms play an essential role in interactome-based research. PPI 
databases are not only important for studying intracellular interactions, but also for 
studying interactions between different species, such as host-pathogen interactions, which 
contributes to our understanding of bacterial physiology and pathogenesis at the host-
pathogen interface120. These interspecies PPIs could lead to the identification of clinically 
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significant interactions with implications for drug treatments. An example of this is the 
maraviroc anti-HIV drug which prevents HIV infection of CD4 T-cells by inhibiting the 
interaction between HIV protein gp120 and chemokine receptor 5121. PPIs can be used to 
design target-specific drug treatments or multi-target drug treatments that are aimed at 
shortening current drug therapies and offer a new avenue to explore given the burden of 
drug resistance122.  
The use of high-throughput techniques has given us valuable information on 
thousands of PPIs stored in various databases. However, a large proportion of these 
interactions are false and therefore validation of high-throughput PPI data is required to 
provide a reliable and comprehensive interaction network. Few PPI databases exist, only 3 
of which are specific for bacteria, namely MPIDB, MPI-LIT and PATRIC. As useful as these 
databases are, many of the large datasets are incomplete or unreliable, with poor consensus 
when cross-comparing PPI datasets between databases. To date, there is no complete and 
reliable PPI database for mycobacteria and the number of interactions confirmed using low-
throughput techniques is even lower. Resolving this problem would be a step in the right 
direction toward a complete and reliable global interaction network for mycobacteria. This 
will aid in the understanding of virulence pathways and the mechanisms by which M. 
tuberculosis evades the immune response. 
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Chapter 2: Research rationale 
2.1. Background 
Iron-sulphur (Fe-S) clusters are chemically versatile cofactors that are found in all 
living organisms and in M. tuberculosis approximately 50 proteins are predicted to require 
an Fe-S cluster for their function123. These proteins are involved in various biological 
processes including DNA repair, RNA modification, redox signalling and central 
metabolism123,124. Multicomponent systems are required for the in vivo assembly of Fe-S 
clusters and three highly conserved systems have been identified in both prokaryotes and 
eukaryotes, namely the NIF (nitrogen fixation), ISC (Fe-S cluster) and SUF (sulphur 
mobilization) systems123–125. 
In M. tuberculosis, a single operon (Rv1460-Rv1461-Rv1462-Rv1463-csd-Rv1465-
Rv1466) displays homology to genes in the SUF system33. With the exception of Rv1460, all 
the genes in the suf operon were predicted to be essential in vitro by forward genetic 
screens, suggesting an important role of Fe-S cluster assembly in the survival of M. 
tuberculosis34,126. Additionally, Rv1460 was predicted to be essential in vivo and shown to be 
induced in the sputum of TB patients, suggesting a significant contribution of Fe-S cluster 
assembly to M. tuberculosis pathogenicity35. Fe-S cluster containing proteins can be 
inactivated in the presence of reactive oxygen and nitrogen species. Exposure to oxidative 
stress causes Fe-S clusters to become oxidised, resulting in the release of iron, which in turn 
causes a further increase in oxidative stress124. Due to the fact that M. tuberculosis is 
exposed to oxidative and nitrosative stressors within the host, Fe-S cluster assembly is most 
likely tightly regulated, as these harsh conditions would be toxic to Fe-S cluster containing 
proteins124. In addition, anti-TB drugs such as clofazamine and isoniazid have previously 
been shown to generate reactive oxygen species, suggesting a crucial role for Fe-S cluster 
assembly in M. tuberculosis drug susceptibility127. The first step in the synthesis of Fe-S 
clusters requires a cysteine desulphurase, which catalyses the transfer of sulphur from L-
cysteine to a scaffold protein. Fe-S clusters are then assembled on the scaffold and 
transferred either directly or via carrier proteins to the apoprotein123,124.  
Rv1460 encodes a probable transcriptional regulator which displays partial homology 
to the SufR gene found in Synechocystis sp. strain PCC 680333,82. SufR contains an Fe-S 
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cluster and functions as a repressor of the suf operon in cyanobacteria128,129. Rv1460 is 
hypothesised to function similarly. Rv1461 encodes a SufB homolog which is highly 
conserved between many organisms and is thought to be the sulphur acceptor in the first 
step of Fe-S cluster assembly as interaction studies have shown that SufB interacts weakly 
with Csd33,82. Rv1462 is a conserved hypothetical which is orthologous to the E. coli SufD, 
while Rv1463 encodes a probable conserved ATP-binding protein ABC transporter and is 
orthologous to the E. coli SufC. SufC interacts strongly with SufB and SufD, and these three 
proteins are likely to form the scaffold on which the Fe-S cluster is assembled. Rv1464 (csd) 
encodes a NifS-like protein and is a cysteine desulphurase orthologous to the E. coli SufS. 
Rv1465 encodes a NifU-like protein of unknown function which is an ortholog of the E. coli 
IscU (a scaffold protein). Rv1466 is a conserved hypothetical that does not display homology 
to any of the previously identified suf genes. The suf operon of M. tuberculosis is atypical 
since no SufA and SufE homologues have been identified33,82. The iron donor remains 
unknown. 
The isc operon of M. tuberculosis lacks several genes required for the function of the 
ISC system in other organisms, however IscS (NifS homolog) is conserved38. Singh et al. 
showed that IscS (Rv3025c) alone is sufficient for the assembly of the Fe-S cluster in the 
WhiB3 transcriptional regulator, in vitro130. Although IscS does not interact with any of the 
proteins in the SUF system, it has been shown to interact with Fe-S cluster containing 
proteins. Deletion of iscS in M. tuberculosis resulted in impaired activity of enzymes 
containing Fe-S clusters, suggesting that IscS is involved in Fe-S cluster assembly38.  
2.2. Problem statement and research question 
Iron-sulphur (Fe-S) cluster biogenesis is a poorly understood area of M. tuberculosis 
physiology. Sequence analysis of the genome of M. tuberculosis revealed a single operon 
(Rv1460-Rv1461-Rv1462-Rv1463-csd-Rv1465-Rv1466) which displays homology to Fe-S 
cluster assembly systems33. It is currently unclear if proteins outside of this operon are 
involved in Fe-S cluster assembly.  
This study aims to use a proteomics-based mass spectrometry approach to identify proteins 
which interact with the Fe-S cluster biogenesis machinery in mycobacteria. This will 
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contribute to our understanding of this process in mycobacteria, and has the potential to 
identify novel targets for the development of new anti-TB drugs. 
2.3. Approach 
A proteomic-based mass spectrometry approach was used together with BN-PAGE and 
affinity purification to identify novel proteins involved in Fe-S cluster assembly. 
Mycobacterium bovis BCG is a non-pathogenic, slow-growing mycobacterium which is 
closely related to M. tuberculosis. BCG is a suitable model organism as more than 99% 
amino acid sequence identity is observed for the proteins encoded by the suf operon. This 
organism was utilised for the optimisation of the BN-PAGE and 2D BN/SDS PAGE 
methodology since BL3 conditions are not required. However, due to the fact that this 
organism is so closely related to M. tuberculosis, the methodology developed during this 
study would be applicable to the pathogenic organisms, should the appropriate facilities be 
available.  
Mycobacterium smegmatis is a non-pathogenic fast-growing mycobacterium which is 
closely related to M. tuberculosis, with an amino acid sequence identity of 83% for proteins 
encoded by the suf operon. M. smegmatis was used for all protein expression optimisation 
and affinity purification experiments due to the time constraints of this study.  
2.4. Research hypothesis, aims and objectives   
Hypothesis: Proteins outside of the suf operon are involved in Fe-S cluster assembly. 
Aim: To identify novel proteins which interact with the M. tuberculosis Fe-S cluster 
biogenesis machinery 
Objectives: 
1. To develop the methodology to identify cytoplasmic protein complexes in 
mycobacteria using blue native PAGE (BN-PAGE) and mass spectrometry (MS) 
2. To identify novel proteins which interact with the Fe-S cluster biogenesis machinery 
in M. tuberculosis 
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3. To validate the novel interactions identified using other protein-protein interaction 
techniques  
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Chapter 3: Methods and materials 
3.1. Standard culture conditions 
Escherichia coli strains were grown on Luria Bertani agar solid media overnight at 37  
 C and then cultured to mid-logarithmic phase in  uria  ertani li uid media overnight at 37   C 
with shaking at 200 rpm. Strains were stored as freezer stocks prepared by mixing 1 ml 
culture with glycerol to a final concentration of 12%. Mycobacterium smegmatis strains 
were grown on  A solid media for 3-5 days at 37   C and then cultured in 7H9 li uid media in 
a 5 ml starter culture overnight at 37   C with shaking at 200 rpm. M. smegmatis was then 
sub-cultured to a starting OD600 of 0.05 and grown to mid-logarithmic phase. 
Mycobacterium bovis  C  strains were grown on 7H10 solid media for  3-5 weeks at 37   C 
and then cultured in 7H9 li uid media in a 5 ml starter culture for 5-7 days at 37   C without 
shaking. M. bovis BCG was then sub-cultured to a starting OD600 of 0.05 and grown to mid-
logarithmic phase. Mycobacterial strains were stored as freezer stocks of 1 ml of mid-
logarithmic phase culture at -80   C. Standard culturing conditions are used throughout 
unless otherwise stated. 
Table 3.1. Plasmids used in this study 
Plasmid Description Source 
pET-28a(+) 
Plasmid designed for expression of recombinant proteins 
in E. coli, N- and C-terminal His-tag, T7 promoter, 
Thrombin cleavage site, Kanr 
EMD Millipore 
pGEX-6P-1 
Plasmid designed for expression of recombinant proteins 
in E. coli, N-terminal GST-tag, tac promoter, PreScission 




Plasmid designed for expression of recombinant proteins 
in E. coli, N-terminal MBP-tag, tac promoter, Factor Xa 




Derivative of pET28a(+) carrying M. tuberculosis Rv1464 




Derivative of pGEX-6P-1 carrying M. tuberculosis Rv1464 




Derivative of pMAL-c5X carrying M. tuberculosis Rv1464 
(csd), tac promoter, Ampr 
This work 
pJET 1.2 
Cloning vector for cloning of blunt-end PCR products and 
expression in E. coli, T7 promoter, Ampr 
Thermo 
Scientific 
pSE100 Mycobacterial tetracycline-inducible expression vector, 
derivative of pMS2, Pmyc1tetO promoter, Hygr 
Sabine Ehrt131 





Derivative of pSE100 carrying M. tuberculosis Rv1464 
(csd), modified ribosome binding site, His-tag and 




Derivative of pSE100 carrying M. tuberculosis Rv1463 
(sufc), modified ribosome binding site, His-tag and 




Derivative of pSE100 carrying mCherry, modified 
ribosome binding site, His-tag and thrombin cleavage 
site, Pmyc1tetO promoter, Hygr 
This work 
pTEK-4S-0X Vector expressing reverse TetR for use in mycobacteria, 
derivative of pMS2, psmyc promoter, Kanr 
 Sabine Ehrt131 
*All plasmids used in this study were initially propagated in E. coli DH5-alpha. 
 
Table 3.2. Strains and plasmids used in this study 
Name Description Source 
M. bovis   
BCG Pasteur 1173P2 Pasteur 1173P2; avirulent laboratory strain Laboratory 
stock 
M. smegmatis   







Derivative of mc2 155 carrying M. tuberculosis 
Rv1464 (csd) under the control of Pmyc1tetO 





Derivative of mc2 155 carrying M. tuberculosis 
Rv1463 (sufc) under the control of Pmyc1tetO 






Derivative of mc2 155 carrying mCherry, a codon 
optimised derivative of DsRed isolated from 
Discosoma sp., under the control of Pmyc1tetO 
promotor, integrated at the attB locus, Hygr; ** 
This work 
groEL1ΔC Derivative of mc2 155 carrying a deletion of the 





Derivative of groEL1ΔC carrying M. tuberculosis 
Rv1464 (csd) under the control of Pmyc1tetO 





Derivative of groEL1ΔC carrying M. tuberculosis 
Rv1463 (sufc) under the control of Pmyc1tetO 






Derivative of groEL1ΔC carrying mCherry, a codon 
optimised derivative of DsRed isolated from 
Discosoma sp., under the control of Pmyc1tetO 
promotor, integrated at the attB locus, Hygr; ** 
This work 
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E. coli   





ArcticExpress Avirulent strain optimised for protein expression and 
enhanced solubility of heterologous proteins; 





Derivative of ArcticExpress carrying a plasmid 
expressing a 6xHis-tag fusion with M. tuberculosis 




Derivative of ArcticExpress carrying a plasmid 
expressing a GST-tag fusion with M. tuberculosis 




Derivative of ArcticExpress carrying a plasmid 
expressing a MBP-tag fusion with M. tuberculosis 
Rv1464 (csd) from a tac promotor, Ampr 
This work 
Rosetta-gami Avitulent strain optimised for protein expression of 
proteins containing codons rarely used in E. coli; 





Derivative of Rosetta-gami carrying a plasmid 
expressing a 6xHis-tag fusion with M. tuberculosis 




Derivative of Rosetta-gami carrying a plasmid 
expressing a GST-tag fusion with M. tuberculosis 




Derivative Rosetta-gami carrying a plasmid 
expressing a MBP-tag fusion with M. tuberculosis 
Rv1464 (csd) from a tac promotor, Ampr 
This work 
**Carries plasmid expressing reverse TetR from the psmyc promoter, Kanr   
 





Sequence (5’-3’) Amplicon 
(bp) 



































5’ end of csd 





















































the csd 3’ end 







91 bp upstream 
of the csd 5’ end 




















upstream of the 












the csd 5’ end 







62 bp upstream 
of the gene of 
interest 








the gene of 
interest 








upstream of the 
gene of interest 









the gene of 
interest 




















3’ end of sufc 
*Restriction enzyme sites are underlined 
*Start and stop codons are in bold 
Table 3.4. Growth media and buffer composition 
Growth media Composition 
Luria Bertani agar (LA) 0.5% Yeast extract, 1% Tryptone, 0.5% Sodium chloride (NaCl), 
1.5% agar  
Luria Bertani broth (LB) 0.5% Yeast extract, 1% Tryptone, 0.5% NaCl 
Middlebrook 7H9 
liquid media 
0.47% 7H9 powder, 0.2% glucose, 0.2% glycerol, 0.05% Tween-80 
Middlebrook 7H10 
solid media 
1.9% 7H10 powder, 10% oleic albumin dextrose and catalase 
(OADC), 0.5% glycerol 
Sauton’s minimal 
media 
2% glycerol, 0.4% L-asparagine, 0.2% glucose, 0.2% citric acid, 
0.05% monopotassium phosphate, 0.05% magnesium, 0.05% 
Tween-80, 0.005% ferric ammonium citrate, 0.00001% zinc 
sulphate, pH 7.0 
Buffers  
Lysis buffer 1 50 mM Tris-HCL pH 7.4, 150 mM NaCl, 0.05% Triton X-100, 
c0mplete protease inhibitor cocktail (Roche) 
Lysis buffer 2 50 mM Tris-HCL pH 7.4, 10 mM MgCl2, c0mplete protease 
inhibitor cocktail, 20 U/ml DNase I 
Lysis buffer 3 50 mM Tris-HCL pH 7.6, 100 mM NaCl, 2 mM MgCl2, 0.5% Triton X-
100, c0mplete protease inhibitor cocktail, 25 U/ml Benzoase, 1 
mM Dithiotreitol (DTT)   
Laemmli 2x sample 
reducing buffer 
6% Sodium dodecyl sulfate (SDS), 20% glycerol, 10% β-
Mercaptoethanol (BME), 0.0375% Bromophenol blue, 340 mM 
Tris pH 6.8, 10 mM Ethylenediaminetetraacetic acid (EDTA) 
Laemmli running buffer  25 mM Tris, 192 mM Glycine, 0.1% SDS 
Transfer buffer 1 25 mM Tris, 192 mM Glycine, 20% Methanol (MeOH) 
TBS-T wash buffer 20 mM Tris pH 7.6, 137 mM NaCl, 0.1% Tween-20 
Blocking buffer TBS-T wash buffer + 10% fat free milk powder 
Tris-acetate-edetic acid 
(TAE) 
40 mM Tris pH 7.6, 1 mM EDTA pH 8.0, 20 mM acetic acid 
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3.2. Preparation of competent cells 
3.2.1. Chemically competent E. coli 
E. coli (DH5-Alpha and ArcticExpress) was cultured in 5 ml of double-strength LB 
supplemented with 0.2% glucose liquid media overnight with shaking at 200 rpm. A 
concentration of 20 µg/ml gentamycin was added for ArcticExpress. ArcticExpress was 
cultured at 30   C, while DH5-Alpha was cultured at 37   C. The culture was diluted 1:100 in 
the same media and cultured to an OD600 of 0.3-0.4. Cells were harvested by centrifugation 
in a GSA rotor at 4500 x g at 4   C. All subsequent steps were performed on ice. Cells were 
resuspended in 100 ml of ice-cold 100 mM CaCl2 containing 15% glycerol and incubated on 
ice for 20-30 min. Cells were then harvested by centrifugation at 4500 x g for 10 min at 4   C. 
Cells were resuspended in 10 ml of an ice-cold 100 mM CaCl2 solution containing 15% 
glycerol. Ali uots of 100 μl were made, flash frozen in li uid nitrogen and stored at -80   C 
until required. 
3.2.2. Electrocompetent E. coli 
E. coli Rosetta-gami was cultured in 50 ml LB media containing 34 µg/ml 
chloramphenicol, 50 µg/ml streptomycin, and 12.5 µg/ml tetracycline. Eight 500 ml flasks 
each containing 250 ml LB media (34 µg/ml chloramphenicol, 50 µg/ml streptomycin, and 
12.5 µg/ml tetracycline) were incubated overnight at 37   C with shaking at 200 rpm. Five 
millilitres of E. coli culture was inoculated into each of the eight flasks and incubated at 37   C 
with shaking at 200 rpm for 3-4 hours. Once an OD600 of 0.7 had been reached, cells were 
harvested by centrifugation in 6x250 ml centrifuge tubes in a GSA rotor for 10 min at 4500 x 
g at 4   C. Cells were washed three times (50 ml, 20 ml and 10 ml washes) in ice-cold 10% 
glycerol and pooled together in a 50 ml Falcon tube at the final wash step. The pellet was 
resuspended in 2 ml 10% ice cold glycerol per 1 L of original culture. Aliquots were made of 
100 μl each and flash-frozen in liquid nitrogen and stored at -80   C. 
3.2.3. Electrocompetent M. smegmatis 
M. smegmatis was cultured under standard conditions in 50 ml 7H9 liquid media 
until an OD600 of ~1 was reached. Cells were harvested by centrifugation at 4500 x g for 10 
min at 4   C. Cells were resuspended in 50ml 10% ice-cold glycerol containing 0.05% Tween-
80 and harvested by centrifugation as described above. This wash was repeated with 20 ml 
Stellenbosch University  https://scholar.sun.ac.za
25 
 
and 10 ml, and cells were finally resuspended in ~2 ml 10% ice-cold glycerol with 0.05% 
Tween-80.    
3.2.4. Electrocompetent M. bovis BCG  
M. bovis BCG was cultured under standard conditions in 50 ml 7H9 liquid media until 
an OD600 of ~1 was reached. Cells were harvested by centrifugation at 4 500 x g for 10 min at 
room temperature (  ). Cells were washed 3  mes in e ual volumes of 10% glycerol with 
0.05%  ween-80, pre-heated to 37    C. Cells were resuspended in ~2 ml 10% glycerol with 
0.05% Tween-80.   
3.3. Cloning and molecular biology methods 
PCR reactions for gene amplification were performed using ThermoFisher Scientific 
Phusion High-Fidelity DNA Polymerase according to manufacturer’s instructions. Colony PC  
was performed using the KAPA Biosystems KAPA2G Robust HotStart ReadyMix PCR Kit 
according to manufacturer’s instructions. 
DNA was extracted using the NucleoBond® PC 100 Nucleic Acid and Protein 
Purification kit (Separations) or the Wizard® plus SV MiniPreps DNA Purification kit 
(Promega) according to manufacturer’s instructions. For restriction enzyme digests, 10 units 
of enzyme were used to digest 1 μg of plasmid DNA in 3 hours at 37   C in a 20 μl reaction. 
DNA electrophoresis gels were prepared using 0.8% agarose in TAE buffer containing 
0.005% 10 mg/ml Ethidium bromide. Gel slices were purified using the Wizard® SV Gel and 
PCR Cleanup Kit (Promega) and the standard protocol was followed according to 
manufacturer’s instructions. DNA was  uantified using the Nanodrop® ND1000 
Spectrophotometer (Thermo Scien  c).  iga on reac ons were performed using a 1 3 ra o 
of vector to insert (0.05 pmol ends   0.15 pmol ends) in a 15 μl reac on with 3 units of  4 
ligase (Promega) at 4   C overnight.   
3.4. Transformation 
3.4.1. Chemically competent E. coli 
E. coli competent cells were thawed on ice. A volume of 100 µl of competent cells 
were added to the entire ligation mix and incubated on ice for 10 minutes. The 
transformation mixture was then incubated at 37   C for 10 min and immediately placed back 
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on ice. A volume of 1 ml of LB liquid media was added to the transformation mixture and 
incubated for 1 hour at 37   C for cells to recover. The transformation mixture was then 
concentrated to 100 μl and plated on  A solid media, followed by incubation at 37   C until 
visible growth was observed. 
3.4.2. Electro-competent cells 
3.4.2.1. E. coli 
E. coli competent cells were thawed on ice. A volume of 40 µl of competent cells 
were added to 2 μl of the ligation mixture or 20 ng of circular plasmid DNA and incubated on 
ice for 5 min. The transformation mixture was transferred to an electroporation cuvette and 
electroporation performed using the  io  ad MicroPulser™ (Setting   acteria; Program  Ec2; 
2.5 kV; 25 μF; 200 Ω). A volume of 400 µl of LB media was added to the cuvette and 
transferred to a 1.5 ml Eppendorf tube and incubated for 1 hour at 37   C for cells to recover.  
A volume of 100 µl of the transformation mixture was then plated on LA solid media, 
followed by incubation at 37   C until visible growth was observed. 
3.4.2.2. M. smegmatis and M. bovis BCG 
A volume of 400 µl of competent cells were added to 500-1000 ng of plasmid DNA 
and incubated on ice for M. smegmatis and 37   C for M. bovis BCG for 5 min. The 
transformation mixture was then transferred to an electroporation cuvette and 
electroporations were performed with the following settings  2.5 kV, 25 μF and 1000 Ω. 
After each electroporation, 800 μl of 7H9 li uid media was added to cuvette and then 
transferred to a 1.5 ml Eppendorf tube and incubated at 37   C cells to recover. M. 
smegmatis cells were incubated for 3 hours and then plated on LA solid media and M. bovis 
BCG cells were incubated for 24 hours and plated on 7H10 solid media.  
3.5. Sanger sequencing 
All DNA sequencing was performed at the Central Analytical Facility (CAF) at 
Stellenbosch University and analysed using Sequencher DNA sequence analysis software133. 
Stellenbosch University  https://scholar.sun.ac.za
27 
 
3.6. M. smegmatis and M. bovis BCG growth curves 
M. smegmatis and M. bovis BCG strains were cultured at a starting OD600 of 0.05 
under standard conditions and OD600 readings recorded every 3 hours for M. smegmatis and 
every 48 hours for M. bovis BCG. All growth curves were done in 3 biological replicates. 
3.7. Protein over-expression in E. coli 
Plasmids for the expression of recombinant Csd were transformed into E. coli 
ArcticExpress and Rosetta gami strains. Single colonies were picked and inoculated into 5 ml 
LB media containing 20 µg/ml gentamycin for ArcticExpress and 34 μg/ml chloramphenicol, 
50 μg/ml streptomycin and 12.5 µg/ml tetracycline for  osetta gami, and cultured under 
standard conditions. The starter culture was sub-cultured in LB media containing the above 
mentioned antibiotics and incubated at 30   C for ArcticExpress and 37   C for Rosetta-gami 
for 2-4 hours to obtain an OD600 of 0.4. Isopropyl β-D-1-thiogalactopyranoside (IPTG) was 
added to a final concentration of 0.4 mM and incubated overnight at 13   C for ArcticExpress 
and standard conditions for Rosetta gami. Cells were harvested after 24 hours by 
centrifugation at 4500 x g for 10 min at 4   C. Pelleted cells were stored at -80   C overnight or 
until use. Uninduced and empty vector strains were included as controls. 
3.8. Construction of 6xHis-tag fusion proteins 
csd along with the pET-28a(+) ribosome binding site (rbs), 6xHis-tag and thrombin 
cleavage site was excised from pET28a(+)-csd with XbaI and HindIII and subsequently ligated 
into pSE100 at the same restriction sites to generate pSE100-rbs-csd. The pSE100-rbs-csd 
vector was then digested with NdeI and HindIII to remove csd only. sufc and mcherry were 
then ligated into the modified pSE100 vector to generate pSE100-rbs-sufc and pSE100-rbs-
mcherry, respectively. 
3.9. Optimisation of 6xHis-tag fusion protein expression 
M. smegmatis mc2 155 derivatives, M. smegmatis mc2 155 attB::pSE100-rbs-csd (pTEK-4S-
0X), M. smegmatis mc2 155 attB::pSE100-rbs-sufc (pTEK-4S-0X) and M. smegmatis mc2 155 
attB::pSE100-rbs-mcherry (pTEK-4S-0X), were cultured under standard conditions. Starter 
cultures were grown in the presence of 10 ng/ml anhydrotetracycline (atc). Atc is used to 
control gene expression in the tetracycline-responsive gene expression system, used here. 
Starter cultures were subsequently washed twice with culture media and subcultured to an 
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OD600 of 0.05 in media containing either 0 ng/ml atc or 10 ng/ml atc. Aliquots were removed 
from each culture at 0, 16, 24 and 36 hours. Cells were harvested by centrifugation 4500 x g 
and protein extractions performed as described below. Both the soluble and insoluble 
protein fractions were collected and analysed by SDS-PAGE using the Bio-Rad 4-15% Mini-
PROTEAN® TGX Stain-Free™  els. Proteins were transferred to a PVDF membrane. A 
primary anti-6xHis-tag antibody (Abcam), diluted 1:1000, and a secondary HRP-conjugated 
goat anti-rabbit antibody, diluted 1:10000, were used for western blot immunodetection. 
Gels, membranes and chemiluminescent detection was done using the Bio- ad ChemiDoc™ 
MP system. The Bio- ad Image  ab™ software was used to normalise the intensity of the 
band detected on the Western blot to the total protein loaded in each lane.  
3.10. Affinity purification using MagneHis™ beads  
Affinity purification of 6xHis-tagged proteins was performed using paramagnetic pre-
charged nickel particles (MagneHis™ Ni-Particles) under native conditions. M. smegmatis 
strains were cultured under standard conditions in the absence of atc for 16 hours. Cells 
were harvested by centrifugation at 4500 x g, washed twice with PBS and stored at -80   C. 
Cell pellets from 5 ml culture were resuspended in 1 ml of lysis buffer 3 and cells were lysed 
as described above. MagneHis™ Ni-Particles were added to 1 ml of protein lysate and 
protocol followed according to manufacturer’s instructions. The purification procedure was 
optimised by testing different volumes of MagneHis™ Ni-Particles per 1 ml protein lysate as 
well as the influence of high (500 mM) and low (100 mM) NaCl concentrations. 
3.11. H2O2 and NO exposure of M. bovis BCG 
M. bovis BCG was cultured under standard conditions until an OD600 of ~1. For H2O2 
exposure, 5 mM or 10 mM H2O2 was added to the culture, and aliquots removed at 40 min, 
1 hour and 3 hours post addition. Cells were then harvested and proteins extracted as 
described below. For NO exposure, 0.5 mM or 1 mM diethylenetriamine/nitric oxide adduct 
(DETA/NO) was added to the culture and aliquots removed at 40 min and 4 hours. Cells 
were then harvested and proteins extracted as described below. 
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3.12. Bacterial lysis and protein extraction 
Cells were cultured under standard conditions unless otherwise stated. Cells were 
harvested by centrifugation at 4500 x g and washed twice in e ual volumes of phosphate 
bu ered saline (P S). Cell pellets were stored at -80  C overnight or until use.  
3.12.1. Sonication 
M. bovis BCG, M. smegmatis or E. coli cell pellets were resuspended in 1 ml lysis 
buffer and sonicated 3 times at 50 Hz for 20 sec with 2 min incubations on ice between each 
sonication step. The lysate was then clarified by centrifugation in a microfuge at maximum 
speed for 30 min at 4   C.            
3.12.2. Bead-beating 
M. bovis BCG cell pellets were resuspended in 1 ml lysis buffer and transferred to 2 
ml cryogenic tubes with O-rings containing glass beads. Cells were mechanically lysed by 
bead-beating 6 times for 20 sec each at a speed of 4.0 m.s-1, with 1 min intervals for cooling 
on ice. Beat-beating was performed using a Ribolyser (Bio101 Savant, Vista, CA). The lysate 
was clarified by centrifugation in a microfuge at maximum speed for 30 min at 4   C.            
3.13. Buffer exchange  
Protein samples were dialysed using the ThermoFisher Scientific Slide-A- yzer™ MINI 
Dialysis Devices with a molecular weight cut-off of 3.5 kDa. A volume of 100 µl of protein 
samples was dialysed in 1 ml of buffer according to manufacturer’s instructions. 
3.14. Protein concentration determination 
Protein concentrations were determined using the RC DCTM Protein Assay (Bio-Rad) 
according to manufacturer’s instructions. Bovine serum albumin was use as the protein 
standard and standard curve concentrations ranged from 0 – 2 mg/ml. Dilutions were made 
where needed to ensure concentrations were within the range of the standard curve. The 
RC DCTM Protein Assay is a modified colorimetric Lowry assay compatible with reducing 
reagents and detergents. 
3.15. SDS-PAGE 
NuPAGE® Bis-Tris 4-12% Mini Gels were used to run all SDS-PAGE gels, unless 
otherwise indicated, using the XCell SureLock® Mini-Cell electrophoresis system according to 
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manufacturer’s instructions. NuPA E 2-(N-morpholino)ethanesulfonic acid (MES) buffer was 
used and NuPA E  ithium Dodecyl Sulfate ( DS) sample bu er and NuPA E sample reducing 
agent were added to samples to a  nal concentra on of 1x and heated for 10 min at 70   C. 
Gels were run at a constant 200 V. Prior to loading, the protein concentration of each 
sample was determined and the volume adjusted to ensure that the same amount of 
protein was loaded in each lane (~25 µg). 
Bio-Rad 4-15% Mini-PROTEAN® TGX Stain-Free™  els were used for protein 
expression optimisation. Stain-free gels contain a trihalo compound that interacts with the 
tryptophan content in proteins and allows for fluorescent detection of whole protein lysates 
using the Bio- ad ChemiDoc™ MP system.  el images were analysed using  io-Rad Image 
 ab™ software.  els were run with  aemmli sample running buffer and samples were mixed 
with an equal volume of Laemmli 2x sample reducing buffer prior to loading and heated for 
10 min at 70   C. Gels were run at a constant 200 V. 
Bio-rad gels with an acrylamide/bisacrylamide concentration of 12% were made 
according to manufacturer’s instructions and used for the analysis of affinity purified protein 
samples. Gels were run with Laemmli sample running buffer and samples were mixed with 
an equal volume of Laemmli 2x sample reducing buffer prior to loading and heated for 10 
min at 70   C. Gels were run at a constant 200 V. 
3.16. BN-PAGE and 2D BN/SDS-PAGE 
BN-PA E was performed using the NativePA E™ Novex® 4–16% Bis-Tris Gels using 
the XCell SureLock® Mini-Cell electrophoresis system according to manufacturer’s 
instructions. Prior to loading, the protein concentration of each sample was determined and 
the volume adjusted to ensure that the same amount of protein (~25 µg) was loaded in each 
lane.  he NativePA E™  is-Tris non-denaturing buffer system was used and samples were 
mixed with NativePA E™ Sample  uffer to a 1x final concentration.  els were run at 4   C for 
1 hour at 150 V and then for another hour at 250 V. NativeMark™ Unstained Protein 
Standard was used as a molecular weight marker. 
NuPAGE® 4-16% Bis-Tris Gel with a 6.5 cm 2D-well was used for 2D BN/SDS-PAGE 
according to manufacturer’s instructions.  he NuPA E MES buffer system was used.  els 
were run at a constant 200 V. 
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3.17. Western blot 
Unless otherwise stated, a primary anti-6xHis-tag antibody (Abcam), diluted 1:1000, 
and a secondary HRP-conjugated goat anti-rabbit antibody, diluted 1:10000, were used for 
Western blot immunodetection. 
NuPAGE SDS-PAGE gels were transferred to the Amersham Hybond ECL 
nitrocellulose blotting membrane with a pore size of 0.45 µm using the Bio-Rad Trans-Blot 
 urbo  ransfer System according to manufacturer’s instructions. Proteins were transferred 
using transfer buffer 1 at 100 V at 4   C. The membrane was then blocked overnight with 
blocking buffer. The membrane was washed three times for 10 min with TBS-T wash buffer 
and then incubated with the primary antibody for 1 hour. TBS-T washes were repeated and 
the membrane incubated with the secondary antibody for 1 hour, followed by another 3 
TBS-T washes. The membrane was then incubated for 5 min with Amersham ECL Western 
 lotting Detection  eagent according to manufacturer’s instructions. Chemiluminescent 
protein banding patterns were detected and analysed using the Thermo Scientific CL-
XPosure Film which was developed using the Amersham pharmacia biotech Hyperprocessor. 
Bio-Rad Mini-PROTEAN® TGX Stain-Free™ gels were transferred to the Amersham 
Hybond P PVDF blotting membrane with a pore size of 0.45 µm using the Bio-Rad Trans-Blot 
Turbo Transfer System according to manufacturer’s instructions. All further steps were 
performed as stated above. Chemiluminescent protein banding patterns were detected and 
analysed using the Bio- ad ChemiDoc™ MP system.  otal protein lysates were used for 
normalisation. Transfer and blot images were analysed using Bio- ad Image  ab™ software. 
BN-PAGE gels were transferred to the Amersham Hybond P PVDF blotting membrane 
with a pore size of 0.45 µm using the Bio-Rad Trans-Blot Turbo Transfer System according to 
manufacturer’s instructions. NuPAGE transfer buffer was used and chemiluminescent 
protein banding patterns were detected and analysed using the Thermo Scientific CL-
XPosure Film which was developed using the Amersham pharmacia biotech Hyperprocessor. 
3.18. Mass spectrometry 
LC-MS/MS analysis of MagneHis purifications was performed at the Centre for 
Proteomic and Genomic Research (CPGR). Four 1 ml aliquots of each protein lysate was 
mixed with 60 µl of MagneHis beads, and the purification performed as described above. 
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The complexes eluted from these purifications were subsequently pooled together and 
concentrated using the Millipore Amicon® Ultra 0.5 ml Centrifugal Filters with a molecular 
weight cut-off of 3 kDa. Approximately 25 µg of sample was loaded per lane and run ~1 cm 
into a NuPAGE® Bis-Tris 4-12% Mini Gel. The entire sample in each lane was excised and the 
gel piece cut into 1 mm x 1 mm cubes and stored in HPLC-grade water (Sigma-Aldrich) in 1.5 
ml Eppendorf tubes. Three biological replicates were prepared for each sample. Samples 
were processed according to the standard operating procedures for in-gel digestion at 
CPGR. In short, proteins were reduced in 2 mM tris-carboxyethyl phosphine and 25 mM 
ammonium bicarbonate and alkylated in 20 mM iodoacetamide and 25 mM ammonium 
bicarbonate. In-gel protein digestion was performed using 0.2 mg/ml trypsin and 50 mM 
ammonium bicarbonate and resulting peptides were extracted from the gel slices. Peptides 
were then separated by reverse-phase high performance liquid chromatography (R-HPLC) 
and analysed using the Q-Exactive Quadrupole-Orbitrap mass spectrometer (Thermo Fisher 
Scientific, USA) coupled with a Dionex Ultimate 3000 nano-HPLC system. Details of 
chromatographic separation and LC-MS/MS analysis can be found in supplementary file 1. 
Details of search parameters can be found in the summary sheet of Byonic output (raw 
data) for each replicate in supplementary folder 1.  Precursor intensity was used for label-
free quantification. Spectra obtained from the mass spectrometer were analysed using the 
 yonic™ Protein Metrics software134 and a list of identified protein candidates obtained for 
biological replicates. LC-MS/MS data was filtered to remove known contaminants and to 
retain only proteins that had two or more unique peptides. Perseus, as part of MaxQuant135 
software was used for further data analysis. The data were log2 transformed and imputation 
of missing data was performed to replace missing values with random values drawn from a 
normal distribution that mimics the signal of low abundant proteins.  Matrices containing 
imputed values were only used for cluster analysis and a Z-score was computed prior to 
principle component analysis. The original log2 transformed data, prior to imputation, were 
subsequently filtered for rows which contained 3 valid values for each group. An ANOVA 
with Benjamini Hochberg correction was performed to determine significant difference 
between groups and a fold change of 2 standard deviations from the mean between the test 
and control was included as statistically enriched. Proteins that were present in all 3 
replicates in the Csd or SufC samples and not present in the mCherry control were selected 
when filtering for the high stringency list. For the intermediate stringency list, we chose 
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proteins that were present in all 3 replicates in the Csd and SufC affinity purified samples 
and either not present at all or only detected once in the mCherry control. Differentially 
enriched proteins were added to both the stringent and intermediate stringency lists. Venny 
2.0.2136 was used to construct a Venn diagram of proteins common to both the Csd and SufC 
enrichment. Gene ontology terms were retrieved from UniProt137. STRING114 version 10 was 
used to visualize interaction networks.    
LC-MS/MS analysis of the RNA polymerase complex was performed at Stellenbosch 
University Central analytical facility (CAF) on a Dionex Ultimate 3000 nano-LC system 
connected to a linear quadropole ion trap–Orbitrap (LTQ-Orbitrap) Fusion Tribrid mass 
spectrometer equipped with a nanoelectrospray ion source. The gel fraction was excised 
from the NativePA E™ Novex® 4–16% Bis-Tris Gel and cut into 1 mm x 1 mm cubes and 
dehydrated using 100% acetonitrile. This sample was processed according to standard 
operating procedures of CAF. Proteins were digested and peptides separated by liquid 
chromatography. MS spectra was analysed using X! Tandem, MyriMatch and Sequest search 
engines. Details of search parameters can be found in supplementary file 2. Raw data can be 
found in supplementary file 3. Data was filtered for proteins that have 2 or more unique 
peptides that map to it. Gene ontology terms were retrieved from UniProt137. 
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Chapter 4: Results 
4.1. Method development and optimisation 
4.1.1. Assessing the growth of M. bovis BCG Pasteur 1173P2 under standard conditions 
In order to identify the optical density that corresponds to mid-logarithmic (midlog) 
growth phase for the M. bovis BCG Pasteur 1173P2 strain under standard conditions, we 
measured OD600 over a period of 18 days. (Fig. 4.1).  An OD600 of ~1 was chosen as midlog 
phase and used for all subsequent experiments. 













Figure 4.1. Growth of M. bovis BCG Pasteur 1173P2 under standard conditions. M. bovis 
BCG Pasteur 1173P2 cultured under standard conditions over 18 days from a starting OD600 
of 0.05. An average of 3 biological replicates plotted with error bars (standard deviation). 
 
4.1.2. Optimisation of Blue-native PAGE  
Blue native polyacrylamide gel electrophoresis (BN-PAGE), originally developed for 
the analysis of mitochondrial protein complexes138, is a specialised electrophoresis method 
which is relatively simple and sensitive and has also been applied for the analysis of 
cytosolic protein complexes139. Here we optimised BN-PAGE for the analysis of 
mycobacterial cytosolic protein complexes. Bead-beating and sonication were compared as 
cell lysis methods prior to BN-PAGE analysis (Fig. 4.2) by comparing the protein yield and the 
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banding patterns of cytoplasmic proteins extracted from M. bovis BCG. Sonication yielded 
the highest concentration of protein and was therefore selected as the lysis method for 
further analysis. The effect of DNase I treatment (20 U/ml) and dialysis on the banding 
patterns were also assessed. DNase I treatment appeared to improve the banding pattern 
by decreasing sample streaking due to DNA-protein association and was included in all 
subsequent experiments. Buffer-exchange did not appear to have any effect on the banding 
pattern and was not included in subsequent experiments.  
 
Figure 4.2. Optimisation of extraction procedures for analysis of cytoplasmic complexes by 
Blue Native PAGE. 4-16% BN-PAGE gel of M. bovis BCG cytoplasmic proteins when using 
bead-beating and sonication as cell-lysis techniques, respectively. Lane 1: bead-beating; lane 
2: sonication; lane 3: bead-beating and DNase I treatment; lane 4: sonication and DNase I 
treatment; lane 5: bead-beating, DNase I treatment and dialysis; lane 6: sonication, DNase I 
treatment and dialysis; lane 7 and 8: bead-beating and sonication samples normalised by 
protein concentration. 
 
4.1.3 Immunodetection of the RNA polymerase complex using BN-PAGE and Western 
blotting 
Immunodetection of a well characterised multiprotein complex, RNA polymerase, 
was used to verify if selected protein complexes could be identified using BN-PAGE. 
Stellenbosch University  https://scholar.sun.ac.za
36 
 
Cytoplasmic protein complexes were extracted from M. bovis BCG and M. smegmatis and 
analysed by BN-PAGE (Fig. 4.3). A Western blot was performed using an RpoB-specific 
antibody in order to identify the RNA-polymerase complex. The theoretical size of the RNA-
polymerase complex is 407.465 kDa, based on the molecular weights of RpoA, RpoB, RpoC, 
RpoZ, SigA and SigH. On the BN-PAGE, RNA-polymerase appeared to be present in at least 2 
complexes, and both these complexes were detected in the region of the 480 kDa band of 
the Native BN-PAGE marker.  
 
Figure 4.3. Immunodetection of RNA polymerase complex in cytoplasmic fraction 
separated by BN-PAGE.  a) 4-16% BN-PAGE gel showing cytoplasmic protein lysate from M. 
smegmatis in lane 1 and M. bovis BCG in lane 2. b) Western blot of a) using an RpoB-specific 
antibody. 
 
4.1.4. Immunodetection of RpoB following 2D BN/SDS-PAGE 
In order to verify the presence of RpoB in the complexes detected in 4.1.3, the M. 
bovis BCG lane from the BN-PAGE gel was the excised and run in the second dimension 
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under denaturing conditions in order to separate protein complexes into their individual 
components. A signal for RpoB was detected in the expected region, and corresponded 
approximately to the size of the RpoB subunit (~130 kDa) (Fig. 4.4).  
 
Figure 4.4. Immunodetection of RpoB in cytoplasmic fraction separated by 2D BN/SDS-
PAGE. a) 4-16% 2D BN/SDS-PAGE gel of cytoplasmic protein complexes extracted from M. 
bovis BCG. b) Western blot of a) using an RpoB-specific antibody. The region on the second 
dimension gel where RpoB was detected is indicated by the yellow circle. 
 
4.1.5. Validating BN-PAGE using Mass spectrometry 
High-resolution mass spectrometry was used to verify components of the RNA 
polymerase complex identified by immunodetection in section 4.1.3. The BN-PAGE blot was 
overlaid with the BN-PAGE gel and the RNA polymerase complex excised and analysed by 
mass spectrometry (MS). RpoA, RpoB, RpoC and RpoD (SigA) could be detected by MS 
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(identified proteins with gene ontology can be found in the appendix – Table A1).  
Additional proteins were identified that could possibly associate with the RNA polymerase 
complex as detected by experimental and text mining prediction methods using the STRING 
software (Fig. 4.5). When all the STRING prediction methods were used, only 3 proteins 
show no predicted association with this complex, however, the presence of multiple 
complexes migrating to the same position in the gel cannot be ruled out. 
 
Figure 4.5. STRING protein-protein association network showing possible protein 
associations with the RNA polymerase complex as identified by BN-PAGE immunodetection 
and mass spectrometry.  
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4.2. Identifying the Fe-S cluster biogenesis machinery in the M. bovis BCG cytoplasmic 
fraction 
Immunodetection of proteins in mycobacteria is limited by the availability of a 
suitable antibody to detect the protein of interest. Since no antibody against the 
components of the Fe-S cluster biogenesis machinery was available, we initially attempted 
to identify the complex by exposing the organism to conditions that would result in up-
regulation of expression of the complex.  
4.2.1. Hydrogen peroxide and nitric oxide exposure for inducing expression of the Fe-S 
cluster biogenesis machinery 
Reactive oxygen and nitrogen species have previously been shown to upregulate 
genes involved in Fe-S cluster assembly140,141. Here we exposed M. bovis BCG to hydrogen 
peroxide and nitric oxide in order to evaluate if a visible change in levels of protein 
complexes could be observed when analysed by BN-PAGE (Fig. 4.6 – 4.9). The different 
exposure times indicated were chosen due to the fact that upregulation of certain Fe-S 
cluster assembly proteins was observed at these exposure times in previous studies in M. 
tuberculosis on a transcript level140,141. 7H9 liquid media was used as optimal broth for 
standard culturing. Nutrient starvation was previously shown to induce expression of the suf 
operon142. Here we use Sauton’s minimal media in an attempt to enhance suf operon 
expression by using nutrient limitation in combination with exposure to oxidative stress. 
However, no visible difference could be observed. 




Figure 4.6. Separation of cytoplasmic complexes from M. bovis BCG by BN-PAGE following 
H2O2 exposure. 4-16% BN-PAGE gel showing the banding pattern of M. bovis BCG 
cytoplasmic protein complexes after exposure to H2O2 for 40 min and 4 hours under 
standard culture conditions. No visible difference in banding pattern was observed between 
lanes. 




Figure 4.7. Separation of cytoplasmic complexes from M. bovis BCG by BN-PAGE following 
H2O2 exposure. 4-16% BN-PAGE gel showing the banding pattern of M. bovis BCG 
cytoplasmic protein complexes after exposure to H2O2 for 1 hour and 3 hours under 
standard conditions and for 1 hour in Sauton’s minimal media. No visible difference in 
banding pattern was observed between lanes. 




Figure 4.8. Separation of cytoplasmic complexes from M. bovis BCG by BN-PAGE following 
NO exposure. 4-16% BN-PAGE gel showing the banding pattern of M. bovis BCG cytoplasmic 
protein complexes after exposure to DETA/NO for 40 min under standard conditions. No 
visible difference in banding pattern was observed between lanes. 




Figure 4.9. Separation of cytoplasmic complexes from M. bovis BCG by BN-PAGE following 
NO exposure. 4-16% BN-PAGE gel showing the banding pattern of M. bovis BCG cytoplasmic 
protein complexes after exposure to DETA/NO for 4 hours under standard conditions. No 
visible difference in banding pattern was observed between lanes. 
 
4.2.2. Generation of a Csd-specific antibody for identifying the Fe-S cluster biogenesis 
machinery 
Since identification of the Fe-S cluster machinery by hydrogen peroxide and NO 
exposure was unsuccessful, we attempted to generate an antibody directed against one of 
the components of the machinery, namely Csd, to detect the complex by immunodetection. 
In order to do this we needed to express and purify Csd. 
4.2.2.1. Cloning of csd into E. coli expression vectors 
csd was successfully PCR amplified from Mycobacterium tuberculosis H37Rv genomic 
DNA and cloned into three expression vectors (pET28a(+), pGEX-6P-1, pMAL-c5X (plasmid 
maps in appendix). Each construct was transformed into E. coli DH5-alpha and 
transformants plated on LB agar containing the appropriate antibiotic(s). Single colonies 
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were cultured and DNA extractions were performed followed by restriction enzyme 
digestion to screen for the presence of csd (Fig. 4.10 – 4.12), which was subsequently 
confirmed by sequencing. 
 
Figure 4.10. Restriction digestion of pET28a(+) clones to confirm presence of csd. 0.8% 
agarose gel of a pET28a(+)-csd restriction enzyme double digest with BamHI and EcoRV. 
Numbers 1 – 8 indicate the number of colonies that were screened. DNA Molecular Weight 
Marker IV (Sigma). 
 
Figure 4.11. Restriction digestion of pGEX-6P-1 clones to confirm presence of csd. 0.8% 
agarose gel of a pGEX-6P-1-csd restriction enzyme double digest with EcoRI and XhoI. 
Numbers 1 – 8 indicate the number of colonies that were screened. DNA Molecular Weight 
Marker IV (Sigma). 
 
 




Figure 4.12. Restriction digestion of pMAL-c5X clones to confirm presence of csd. 0.8% 
agarose gel of a pMAL-c5X-csd restriction enzyme double digest with EcoRV and EcoRI. 
Numbers 1 – 6 indicate the number of colonies that were screened. DNA Molecular Weight 
Marker IV (Sigma). 
 
4.2.2.2. Heterologous expression of Csd in E. coli ArcticExpress and Rosetta-gami strains  
Three vectors for Csd expression in E. coli were generated, namely, pET28a(+)-csd for 
protein purification using a His-tag (17 kDa), pGEX-6P-1-csd for purification using a GST tag 
(26 kDa), and pMAL-c5X-csd for purification using a maltose-binding protein tag (42 kDa). 
Csd over-expression, in all three vectors, was induced for 24 h in E. coli ArcticExpress and 
Rosetta-gami and analyzed by SDS-PAGE (Fig. 4.13 – 4.18). No visible difference was 
observed for Csd expression in either strain in the soluble fraction (supernatant) compared 
to the empty vector and uninduced control. Csd expression appears predominant in the 
insoluble fraction (pellet). This approach was therefore discontinued. 




Figure 4.13. Expression of Csd from pET28a(+)-csd in E. coli ArcticExpress. 4-12% SDS-PAGE 
of protein fractions obtained after 24 hours of induction of E. coli ArcticExpress harbouring 
either pET28a(+)-csd or pET28a(+). (1) supernatant fraction pET28a(+)-csd, uninduced; (2) 
supernatant fraction pET28a(+), induced; (3) supernatant fraction pET28a(+)-csd, induced; 
(4) pellet fraction pET28a(+)-csd, uninduced; (5) pellet fraction pET28a(+), induced; (6) pellet 
fraction pET28a(+)-csd, induced. Expected band size: 61 kDa 
 




Figure 4.14. Expression of Csd from pGEX-6P-1-csd in E. coli ArcticExpress. 4-12% SDS-PAGE 
of protein fractions obtained after 24 hours of induction of E. coli ArcticExpress harbouring 
either pGEX-6P-1-csd or pGEX-6P-1. (1) supernatant fraction pGEX-6P-1-csd, uninduced; (2) 
supernatant fraction pGEX-6P-1, induced; (3) supernatant fraction pGEX-6P-1-csd, induced; 
(4) pellet fraction pGEX-6P-1-csd, uninduced; (5) pellet fraction pGEX-6P-1, induced; (6) 
pellet fraction pGEX-6P-1-csd, induced. Expected band size: 70 kDa 
 




Figure 4.15. Expression of Csd from pMAL-c5X-csd in E. coli ArcticExpress. 4-12% SDS-PAGE 
of protein fractions obtained after 24 hours of induction of E. coli ArcticExpress harbouring 
either pMAL-c5X-csd or pMAL-c5X. (1) supernatant fraction pMAL-c5X-csd, uninduced; (2) 
supernatant fraction pMAL-c5X, induced; (3) supernatant fraction pMAL-c5X-csd, induced; 
(4) pellet fraction pMAL-c5X-csd, uninduced; (5) pellet fraction pMAL-c5X, induced; (6) pellet 
fraction pMAL-c5X-csd, induced. Expected band size: 86 kDa 




Figure 4.16. Expression of Csd from pET28a(+)-csd in E. coli Rosetta-gami. 4-12% SDS-PAGE 
of protein fractions obtained after 24 hours of induction of E. coli Rosetta-gami harbouring 
either pET28a(+)-csd or pET28a(+). (1) supernatant fraction pET28a(+)-csd, uninduced; (2) 
supernatant fraction pET28a(+), induced; (3) supernatant fraction pET28a(+)-csd, induced; 
(4) pellet fraction pET28a(+)-csd, uninduced; (5) pellet fraction pET28a(+), induced; (6) pellet 
fraction pET28a(+)-csd, induced. Expected band size: 61 kDa 




Figure 4.17. Expression of Csd from pGEX-6P-1-csd in E. coli Rosetta-gami. 4-12% SDS-PAGE 
of protein fractions obtained after 24 hours of induction of E. coli Rosetta-gami harbouring 
either pGEX-6P-1-csd or pGEX-6P-1. (1) supernatant fraction pGEX-6P-1-csd, uninduced; (2) 
supernatant fraction pGEX-6P-1, induced; (3) supernatant fraction pGEX-6P-1-csd, induced; 
(4) pellet fraction pGEX-6P-1-csd, uninduced; (5) pellet fraction pGEX-6P-1, induced; (6) 
pellet fraction pGEX-6P-1-csd, induced. Expected band size: 70 kDa 




Figure 4.18. Expression of Csd from pMAL-c5X-csd in E. coli Rosetta-gami. 4-12% SDS-PAGE 
of protein fractions obtained after 24 hours of induction of E. coli Rosetta-gami harbouring 
either pMAL-c5X-csd or pMAL-c5X. (1) supernatant fraction pMAL-c5X-csd, uninduced; (2) 
supernatant fraction pMAL-c5X, induced; (3) supernatant fraction pMAL-c5X-csd, induced; 
(4) pellet fraction pMAL-c5X-csd, uninduced; (5) pellet fraction pMAL-c5X, induced; (6) pellet 
fraction pMAL-c5X-csd, induced. Expected band size: 86 kDa 
 
4.2.3. Identifying Fe-S cluster biogenesis machinery by affinity purification and MS 
Due to the problem of heterologous mycobacterial protein expression in E. coli, 
experienced in section 4.2.2, we decided to generate 6xHis-tag fusions of components of 
the Fe-S cluster machinery for expression in mycobacteria. We reasoned that these fusion 
proteins could then be used to enrich for the complex of interest by affinity purification 
using a nickel immobilised-metal affinity chromatography (IMAC) resin. Following 
enrichment, potential interacting partners could then be identified by MS. 




4.2.3.1. csd, sufc and mcherry cloning into the pSE100 mycobacterial tetracycline-inducible 
expression vector 
Regulation of gene expression using a tetracycline-responsive expression system 
The tetracycline-responsive expression system (Tet system) has been developed and 
applied in mycobacteria for the controlled regulation of gene expression143. Here we use the 
reverse Tet system, which represses gene expression upon addition of atc, for optimising 
the expression of 6xHis-tag fusion proteins in M. smegmatis.  
 
Figure 4.19. Diagram showing the reverse TetR-mediated regulation of gene expression 
upon addition of atc (adapted from reference 131)131. Reverse TetR is provided by the 
episomal plasmid, pTEK-4S-0X. In the absence of atc, reverse TetR does not bind to the tetO 
operator sites, enabling transcription. Upon addition of atc, reverse TetR binds to the tetO 
operator sites, inhibiting transcription. 
 
Two components of the Fe-S cluster biogenesis machinery, namely Csd and SufC, 
were used for this part of the study. An unrelated protein, mCherry, which has been codon 
optimised for expression in mycobacteria, was included as a negative control for the affinity 
purification study. csd, sufc and mcherry were cloned independently into a modified version 
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of pSE100, which contains a ribosome binding site and N-terminal 6xHis tag. These vectors 
were propagated in E. coli DH5-alpha and screened by restriction enzyme digestion (Fig. 
4.20 – 4.22). Plasmids were confirmed to be correct by sequencing and transformed into M. 
smegmatis mc2 155 along with pTEK-4S-0X to allow for tetracycline-inducible gene 
expression.  
 
Figure 4.20. Restriction enzyme digest of pSE100-rbs-csd. 0.8% agarose gel of a pSE100-rbs-
csd restriction enzyme double digest with XbaI and HindIII. Numbers 1 – 8 indicate the 
number of colonies that were screened. DNA Molecular Weight Marker IV (Sigma). 
 




Figure 4.21. Restriction enzyme digest of pSE100-rbs-sufc. 0.8% agarose gel of a pSE100-
rbs-sufc restriction enzyme double digest with NdeI and HindIII. Numbers 1 – 6 indicate the 
number of colonies that were screened. 




Figure 4.22. Restriction enzyme digest of pSE100-rbs-mcherry. 0.8% agarose gel of a 
pSE100-rbs-mcherry restriction enzyme double digest with NdeI and HindIII. Numbers 1 – 6 
indicate the number of colonies that were screened. 
 
4.2.3.2. Assessing the growth of M. smegmatis strains in the presence and absence of atc 
To test the effect of protein over-expression on cell viability, M. smegmatis mc2 155 
derivatives generated in this study were cultured under standard conditions and the growth 
monitored over 36 hours in the presence and absence of atc (Fig. 4.23 – 4.24). No difference 
in growth between strains was observed. 
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Figure 4.23. Growth curve of M. smegmatis mc2 155 derivatives in the presence of 0 ng/ml 
atc over 36 hours. Circle: M. smegmatis mc2 155 attB::pSE100-rbs-csd (pTEK-4S-0X); Square: 
M. smegmatis mc2 155 attB::pSE100-rbs-sufc (pTEK-4S-0X); Triangle: M. smegmatis mc2 155 
attB::pSE100-rbs-mcherry (pTEK-4S-0X). An average of 3 biological replicates for each strain 
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Figure 4.24. Growth curve of M. smegmatis mc2 155 derivatives in the presence of 10 
ng/ml atc over 36 hours. Circle: M. smegmatis mc2 155 attB::pSE100-rbs-csd (pTEK-4S-0X); 
Square: M. smegmatis mc2 155 attB::pSE100-rbs-sufc (pTEK-4S-0X); Triangle: M. smegmatis 
mc2 155 attB::pSE100-rbs-mcherry (pTEK-4S-0X). An average of 3 biological replicates for 
each strain plotted with error bars (standard deviation). 
 
4.2.3.3. Expression of Csd, SufC and mCherry – 6xHis fusion proteins in M. smegmatis 
In order to optimise the expression of 6xHis-tag fusion proteins expression was 
monitored over time in the absence and presence of anhydrotetracycline (atc). M. 
smegmatis mc2 155 derivatives, M. smegmatis mc2 155 attB::pSE100-rbs-csd (pTEK-4S-0X), 
M. smegmatis mc2 155 attB::pSE100-rbs-sufc (pTEK-4S-0X) and M. smegmatis mc2 155 
attB::pSE100-rbs-mcherry (pTEK-4S-0X), were cultured under standard conditions. Both the 
soluble and insoluble protein fractions were collected and analysed by SDS-PAGE (Fig. 4.25 – 
4.30). In order to determine the expression of Csd relative to the amount of total protein 
extracted, the intensity of the band detected on the Western blot was normalised to the 
total protein detected on the membrane using the Bio- ad Image  ab™ software (Table 4.1 
– 4.4). The majority of 6xHis-tagged proteins were detected in the soluble fraction. Sixteen 
hour culturing in the absence of atc was selected for all subsequent experiments. An 
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intermediate atc concentration of 1 ng/ml was also tested (results not shown), but showed 
a negligible difference from what was observed at 10 ng/ml. 
 
Figure 4.25. Expression of Csd in M. smegmatis mc2 155 attB::pSE100-rbs-csd (pTEK-4S-0X). 
4-15% SDS-PAGE stain-free gel and western blot showing the change in protein expression 
of M. smegmatis mc2 155 attB::pSE100-rbs-csd (pTEK-4S-0X) soluble fraction over 36 hours 
in the presence of 0 ng/ml atc (lane 1-4) and 10 ng/ml atc (lane 5-8). 
Table 4.1. Western blot normalisation of M. smegmatis mc2 155 attB::pSE100-rbs-csd 
(pTEK-4S-0X) soluble fraction 
Lane no. Volume (intensity) Normalisation factor Normalised volume (intensity) 
2 1 884 932 1.000 1 884 932 
3 1 224 608 1.495 1 831 114 
6 463 344 1.270 588 379 
7 582 316 0.730 425 145 
 




Figure 4.26. Expression of SufC in M. smegmatis mc2 155 attB::pSE100-rbs-sufc (pTEK-4S-
0X). 4-15% SDS-PAGE stain-free gel and western blot showing the change in protein 
expression of M. smegmatis mc2 155 attB::pSE100-rbs-sufc (pTEK-4S-0X) soluble fraction 
over 36 hours in the presence of 0 ng/ml atc (lane 1-4) and 10 ng/ml atc (lane 5-8). 
Table 4.2. Western blot normalisation of M. smegmatis mc2 155 attB::pSE100-rbs-sufc 
(pTEK-4S-0X) soluble fraction 
Lane no. Volume (intensity) Normalisation factor Normalised volume (intensity) 
1 136 000 1.000 136 000 
2 1 168 400 0.730 853 277 
3 1 201 300 0.750 901 126 
4 693 400 1.062 736 341 
6 212 900 0.464 98 864 
7 383 100 1.176 450 544 
8 189 600 1.024 194 111 
 




Figure 4.27. Expression of mCherry in M. smegmatis mc2 155 attB::pSE100-rbs-mcherry 
(pTEK-4S-0X). 4-15% SDS-PAGE stain-free gel and western blot showing the change in 
protein expression of M. smegmatis mc2 155 attB::pSE100-rbs-mcherry (pTEK-4S-0X) soluble 
fraction over 36 hours in the presence of 0 ng/ml atc (lane 1-4) and 10 ng/ml atc (lane 5-8). 
Table 4.3. Western blot normalisation of M. smegmatis mc2 155 attB::pSE100-rbs-mcherry 
(pTEK-4S-0X) soluble fraction 
Lane no. Volume (intensity) Normalisation factor Normalised volume (intensity) 
2 1 808 982 1.000 1 808 982 
3 311 346 0.509 158 572 
4 158 572 0.492 59 918 
 




Figure 4.28. Expression of Csd in M. smegmatis mc2 155 attB::pSE100-rbs-csd (pTEK-4S-0X). 
4-15% SDS-PAGE stain-free gel and western blot showing the change in protein expression 
of M. smegmatis mc2 155 attB::pSE100-rbs-csd (pTEK-4S-0X) insoluble fraction over 36 hours 
in the presence of 0 ng/ml atc (lane 1-4) and 10 ng/ml atc (lane 5-8).  




Figure 4.29. Expression of SufC in M. smegmatis mc2 155 attB::pSE100-rbs-sufc (pTEK-4S-
0X). 4-15% SDS-PAGE stain-free gel and western blot showing the change in protein 
expression of M. smegmatis mc2 155 attB::pSE100-rbs-sufc (pTEK-4S-0X) insoluble fraction 
over 36 hours in the presence of 0 ng/ml atc (lane 1-4) and 10 ng/ml atc (lane 5-8). 
Table 4.4. Western blot normalisation of M. smegmatis mc2 155 attB::pSE100-rbs-sufc 
(pTEK-4S-0X) insoluble fraction 
Lane no. Volume (intensity) Normalisation factor Normalised volume (intensity) 
2 4 924 500 1.000 4 924 500 
3 1 501 900 0 989 1 485 879 
4 4 255 200 0.511 2 174 973 
6 684 800 0.716 490 564 
7 311 000 0.618 192 240 
8 1 289 700 0.381 490 812 
 




Figure 4.30. Expression of mCherry in M. smegmatis mc2 155 attB::pSE100-rbs-mcherry 
(pTEK-4S-0X). 4-15% SDS-PAGE stain-free gel and western blot showing the change in 
protein expression of M. smegmatis mc2 155 attB::pSE100-rbs-mcherry (pTEK-4S-0X) 
insoluble fraction over 36 hours in the presence of 0 ng/ml atc (lane 1-4) and 10 ng/ml atc 
(lane 5-8). 
 
4.2.3.4. Enriching for Fe-S cluster machinery by Ni-IMAC affinity purification 
The Hsp60 chaperone, GroEL, is expressed at relatively high levels in M. 
smegmatis132. This is problematic as GroEL has a high affinity for Ni-particles due to its 
histidine-rich C-terminus. To overcome the problem of non-specific co-purification of GroEL, 
M. smegmatis groEL1ΔC was used for enrichment of Fe-S cluster machinery by Ni-NTA. M. 
smegmatis groEL1ΔC is a derivative of M. smegmatis mc2 155 carrying a deletion of the 
histidine-rich C-terminus in GroEL1. To confirm that growth of this strain was not influenced 
by expression of the fusion proteins, growth was monitored under standard conditions in 
the presence and absence of atc over 36 hours (Fig. 4.31 – 4.32). No difference was 
observed in growth when the expression of the fusion proteins was induced.  
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Figure 4.31. Growth curve of M. smegmatis groEL1ΔC derivatives in the presence of 0 
ng/ml atc over 36 hours. Circle: M. smegmatis groEL1ΔC attB::pSE100-rbs-csd (pTEK-4S-0X); 
Square: M. smegmatis groEL1ΔC attB::pSE100-rbs-sufc (pTEK-4S-0X); Triangle: M. 
smegmatis groEL1ΔC attB::pSE100-rbs-mcherry (pTEK-4S-0X). An average of 3 biological 
replicates for each strain plotted with error bars (standard deviation). 














Figure 4.32. Growth curve of M. smegmatis groEL1ΔC derivatives in the presence of 10 
ng/ml atc over 36 hours. Circle: M. smegmatis groEL1ΔC attB::pSE100-rbs-csd (pTEK-4S-0X); 
Square: M. smegmatis groEL1ΔC attB::pSE100-rbs-sufc (pTEK-4S-0X); Triangle: M. 
smegmatis groEL1ΔC attB::pSE100-rbs-mcherry (pTEK-4S-0X). An average of 3 biological 
replicates for each strain plotted with error bars (standard deviation). 




Cytoplasmic extracts from the M. smegmatis groEL1ΔC attB::pSE100-rbs-csd (pTEK-
4S-0X) strain were used to optimise the affinity purification conditions. The influence of the 
volume of MagnaHis™ beads added, and the concentration of salt in the extraction buffer 
on the amount of Csd recovered from 5 ml of cytoplasmic extract were evaluated by SDS-
PAGE and Western blotting. The amount of Csd eluted from the beads appeared to be 
constant for all conditions (Fig. 4.33), however the residual Csd that remained in the 
supernatant fraction decreased as the volume of Ni-particles increased for both the high 
and low salt conditions (Fig. 4.34 & 4.35). The decrease in Csd remaining in the supernatant 
was more dramatic for the high salt conditions (Fig. 4.35). No difference in Csd recovery was 
seen between the 60 µl and 100 µl Ni-particle samples for the low salt supernatant fraction 
(Fig. 4.36). Therefore, 100 mM NaCl and 60 µl of Ni-particles per 5 ml of culture grown for 
16 hours in the absence of atc were used for all subsequent analysis. 
 
Figure 4.33. Optimisation of the affinity purification conditions. 12% SDS-PAGE gel showing 
the enrichment for Csd-associated proteins using 10-, 30-, and 60 µl Ni-particles under high 
(500 mM) or low (100 mM) salt conditions. Immunodetection showing the change in Csd 
recovered from MagnaHis beads under the above mentioned conditions.  




Figure 4.34. Optimisation of the affinity purification conditions. 12% SDS-PAGE gel showing 
the supernatant fraction (unbound Csd) using 10-, 30-, and 60 µl Ni-particles under low (100 
mM) salt conditions. Western blot showing the change in residual Csd under the above 
mentioned conditions for the supernatant fraction. Lane 1: Input sample (before 
enrichment) 




Figure 4.35. Optimisation of the affinity purification conditions. 12% SDS-PAGE gel showing 
the supernatant fraction (unbound Csd) using 10-, 30-, and 60 µl Ni-particles under high 
(500 mM) salt conditions (above). Western blot showing the change in residual Csd under 
the above mentioned conditions for the supernatant fraction (below). Lane 1: Input sample 
(before enrichment) 




Figure 4.36. Optimisation of the affinity purification conditions. 12% SDS-PAGE gel showing 
the supernatant, wash and elute after enrichment for Csd-associated proteins using 60- and 
100 µl Ni-particles under low (100 mM) salt conditions (above). Western blot showing the 
change in Csd expression under the above mentioned conditions (below). Lane 1: Input 
sample (before enrichment) 
 
4.2.3.6. Affinity purification followed by mass spectrometry 
M. smegmatis groEL1ΔC derivatives were cultured under standard conditions and 
affinity purification performed for each strain in 3 biological replicates as optimised in 
section 4.2.3.4. Samples were subsequently run into a NuPAGE gel in order to remove 
contaminants, such as polymers leeched from plastics during sample preparation, 
detergents used in buffers and imidazole used for affinity purification. Gel slices were 
excised and sent for LC-MS/MS analysis. Correlation between replicates was assessed and 
positive correlation with a high Pearson correlation coefficient was observed between 
replicates of the same group. The Pearson correlation coefficient of replicates between 
different groups was lower than that observed between replicates in the same group, 
indicating high reproducibility of affinity purification (Fig. 4.37). Furthermore, principle 
component analysis revealed three distinct clusters, with each biological set clustering 
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together. This confirms high reproducibility of the method and that affinity purifications, 
using mCherry, SufC and Csd as bait proteins respectively, can be separated according to the 
proteins detected by AP-MS (Fig. 4.38).  
Venn diagram analysis revealed 17 common identified proteins in the stringent 
dataset and 18 in the intermediate stringency dataset between proteins identified from the 
Csd and SufC affinity purifications (Fig. 4.39 – 4.40). The SufC affinity purification accounted 
for the bulk of the proteins identified. Gene ontology enrichment revealed that SufC 
associated with many enzymes, some of which are known to be Fe-S cluster containing 
enzymes, such as lipA which encodes a lipoic acid synthetase, ispG which encodes 4-
hydroxy-3-methylbut-2-en-1-yl diphosphate synthase and rlmN which encodes a probable 
dual-specificity RNA methyltransferase (Table 4.5). Identified proteins map to a variety of 
biological processes, the most represented being the regulation of transcription and 
translation. Other biological processes represented by this dataset include DNA repair, 
response to oxidative stress, protein refolding and metal ion transport. Many 
uncharacterised proteins were also identified. STRING networks were constructed using all 
the prediction methods available which show known or predicted protein-protein 
associations, with many identified proteins that have no annotated association with other 
proteins in this network (Fig. 4.41 – 4.42). 
 




Figure 4.37. Multi-scatter plot showing biological replicates with Pearson correlation 
coefficient. 
 




Figure 4.38. Principle component analysis (PCA). PCA of candidate interactors identified by 
AP-MS from the biological triplicate set, when using Csd, mCherry and SufC as bait proteins 
for affinity purification, respectively.  
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Table 4.5. Gene ontology (Molecular function) of proteins enriched by affinity purification 








Csd SufC Csd SufC 







reductase (NADPH) activity 
        
A0R075 Sulfur insertion protein LipA lipA, 
MSMEG_4286, 
MSMEI_4185 
4 iron, 4 sulfur cluster binding; 
lipoate synthase activity; metal ion 
binding 
protein lipoylation        





4 iron, 4 sulfur cluster binding; 
metal ion binding; rRNA (adenine-
C2-)-methyltransferase activity; 
rRNA binding; tRNA (adenine-C2-)-
methyltransferase activity; tRNA 
binding 
rRNA base methylation        
I7G6W7 FO synthase fbiC, 
MSMEI_4998 
4 iron, 4 sulfur cluster binding; 
transferase activity, transferring 




       
A0QVH9 4-hydroxy-3-methylbut-2-en-1-yl 





diphosphate synthase activity; 4 









      
A0QRG9 Aconitate hydratase MSMEG_1112, 
MSMEI_1081 
aconitate hydratase activity         
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Csd SufC Csd SufC 
Q3L887 Acyl-CoA dehydrogenase fadE5, 
MSMEG_0406, 
MSMEI_0396 
acyl-CoA dehydrogenase activity; 
butyryl-CoA dehydrogenase activity 
        
A0QXA4 Acyl-CoA thioesterase II tesB-1, 
MSMEG_3228, 
MSMEI_3146 
acyl-CoA hydrolase activity acyl-CoA metabolic 
process 
       





adenylosuccinate synthase activity; 
GTP binding; magnesium ion 
binding 
'de novo' AMP 
biosynthetic process 
      
A0QT46 LacI-type transcriptional regulator 
(Ribose operon repressor, putative) 
MSMEG_1708, 
MSMEI_1668 
alanine racemase activity; DNA 
binding; transcription factor 




      





alkyl hydroperoxide reductase 
activity; hydroperoxide reductase 
activity; peroxidase activity; 
peroxiredoxin activity 
response to oxidative 
stress 
      
A0R5N8 Aspartokinase ask, 
MSMEG_6257, 
MSMEI_6095 







    
A0R221 Homoserine dehydrogenase MSMEG_4957, 
MSMEI_4830 
amino acid binding; homoserine 







    
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Csd SufC Csd SufC 











      
A0QVI1 Uncharacterized protein MSMEG_2582 antioxidant activity; 
oxidoreductase activity 
        
A0QQU5 60 kDa chaperonin 1 (GroEL protein 




ATP binding protein refolding     
A0QSS4 60 kDa chaperonin 2 (GroEL protein 




ATP binding protein refolding     




ATP binding; copper-exporting 
ATPase activity; metal ion binding 
        
I7GAD8 Probable primosomal protein N' 
(ATP-dependent helicase PriA) 
priA, 
MSMEI_2985 
ATP binding; ATP-dependent DNA 
helicase activity; DNA binding; zinc 
ion binding 
DNA replication, 
synthesis of RNA 
primer; DNA 
unwinding involved in 
DNA replication 
       
A0R563 DNA repair protein RadA homolog radA, 
MSMEG_6079, 
MSMEI_5919 
ATP binding; damaged DNA 
binding; DNA-dependent ATPase 
activity; metal ion binding 
DNA repair        
A0QQT2 DNA or RNA helicase of superfamily 
protein II 
MSMEG_0866 ATP binding; DNA binding; helicase 
activity 
         
A0R4H1 Phosphoribosylformylglycinamidine 




ATP binding; hydrolase activity; 
phosphoribosylformylglycinamidine 
synthase activity 




       
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Csd SufC Csd SufC 






ATP binding; inorganic phosphate 
transmembrane transporter 
activity; phosphate ion 
transmembrane-transporting 
ATPase activity 
        
A0QWR0 Shikimate kinase aroK, 
MSMEG_3031, 
MSMEI_2956 
ATP binding; magnesium ion 
binding; shikimate kinase activity 




      
I7G934 Histidine kinase phoR, 
MSMEI_5712 
ATP binding; phosphorelay sensor 
kinase activity 
         




ATPase activity; ATP binding         
A0R057 Cytochrome c oxidase subunit 2 ctaC, 
MSMEG_4268, 
MSMEI_4167 










phospholipid synthase activity 
lipid biosynthetic 
process 
      





damaged DNA binding; DNA-
(apurinic or apyrimidinic site) lyase 
activity; hydrolase activity, 
hydrolyzing N-glycosyl compounds; 




       









       
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Csd SufC Csd SufC 
A0R4F1 Transcriptional regulator, TetR 
family protein 





      









       
I7F6P9 Transcriptional regulator, TetR 
family 





       









      
A0R4B5 tRNA-dihydrouridine synthase dus, 
MSMEG_5774, 
MSMEI_5620 
flavin adenine dinucleotide 
binding; tRNA dihydrouridine 
synthase activity 




















      
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Csd SufC Csd SufC 





glyoxylate reductase activity; NAD 
binding 
         
A0QS51 Hydrolase, alpha/beta fold family 




hydrolase activity         




phosphatase activity; inositol 
monophosphate 3-phosphatase 




       
A0QS45 50S ribosomal protein L11 rplK, 
MSMEG_1346, 
MSMEI_1308 
large ribosomal subunit rRNA 
binding; structural constituent of 
ribosome 
translation       
A0R749 Uncharacterized protein MSMEG_6779, 
MSMEI_6597 
metal ion binding          






metal ion binding; NAD+ binding; 
protein-malonyllysine 
demalonylase activity; protein-
succinyllysine desuccinylase activity 






      
A0QR94 Ribonucleoside-diphosphate 






metal ion binding; ribonucleoside-
diphosphate reductase activity, 







      
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Csd SufC Csd SufC 





metal ion binding; symporter 
activity 






methyltransferase activity menaquinone 
biosynthetic process 
       




methyltransferase activity         
A0QRA8 Methyltransferase type 11 





methyltransferase activity         
A0QNN7 NAD(P) transhydrogenase subunit 
beta (Nicotinamide nucleotide 





specific) activity; NADP binding 
        
I7FRT7 Mycobacterium tuberculosis 
paralogous family 11 
MSMEI_5079 oxidoreductase activity       
A0R1G3 Clavaldehyde dehydrogenase MSMEG_4742 oxidoreductase activity          





oxidoreductase activity          
A0QQF9 Uncharacterized protein MSMEG_0741, 
MSMEI_0725 
oxidoreductase activity, acting on 
paired donors, with incorporation 
or reduction of molecular oxygen 
        
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Csd SufC Csd SufC 
A0QNG3 Penicillin-binding protein A (PBPA) pbpA, 
MSMEG_0031, 
MSMEI_0033 
penicillin binding; transferase 
activity 
cell wall organization; 
peptidoglycan 
biosynthetic process; 
regulation of cell 
shape 
       
I7FGI9 Pseudouridylate synthase truA, 
MSMEI_1490 




    
A0R220 Threonine synthase thrC, 
MSMEG_4956, 
MSMEI_4829 
pyridoxal phosphate binding; 
threonine synthase activity 
threonine biosynthetic 
process 
       
I7FJ98 RNA-binding protein (Contains KH 
domain)-like protein 
MSMEI_2375 RNA binding          
A0R151 50S ribosomal protein L21 rplU, 
MSMEG_4625, 
MSMEI_4508 
rRNA bindin; structural constituent 
of ribosome 
translation     
A0QS46 50S ribosomal protein L1 rplA, 
MSMEG_1347, 
MSMEI_1309 
rRNA binding; structural 




    





dehydrogenase activity; zinc ion 
binding 
         










       
I7G2S0 Transcriptional regulator, XRE 
family 
MSMEI_0253 sequence-specific DNA binding       
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Csd SufC Csd SufC 
A0QSP9 30S ribosomal protein S9 rpsI, 
MSMEG_1557, 
MSMEI_1520 
structural constituent of ribosome translation     
A0R3B7 Septum formation initiator 
subfamily protein, putative 
MSMEG_5414   cell cycle       
I7G6G4 ChaB family protein MSMEI_1757   DNA-templated 
transcription, 
termination 
      
A0QQP0 Uncharacterized protein MSMEG_0824, 
MSMEI_0805 
        
A0QRV5 Uncharacterized protein MSMEG_1252           
A0R576 Lsr2 protein lsr2, 
MSMEG_6092, 
MSMEI_5934 
          
A0QSQ8 Uncharacterized protein MSMEG_1567, 
MSMEI_1530 
        
A0R595 Uncharacterized protein MSMEG_6112, 
MSMEI_5953 
          




          
A0R4D0 Uncharacterized protein MSMEG_5790, 
MSMEI_5637 
           
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Figure 4.39. Venn diagram showing the proteins that are unique to and common between 
the Csd and SufC affinity purifications for the high-stringency list. 
 
 
Figure 4.40. Venn diagram showing the proteins that are unique to and common between 
the Csd and SufC affinity purifications for the intermediate-stringency list. 




Figure 4.41. Protein association network of proteins identified when using Csd as bait 
protein for affinity purification (Intermediate stringency). 
 




Figure 4.42. Protein association network of proteins identified when using SufC as bait 
protein for affinity purification (Intermediate stringency). 
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Chapter 5: Discussion, future work and concluding remarks 
5.1. Discussion 
Mycobacterium tuberculosis remains a global threat, and our lack of understanding 
of the physiology of this organism is an ongoing challenge in the fight against TB. Protein-
protein interactions are required for a variety of biological processes, such as regulating 
gene expression, mediating the immune response and maintaining structural stability5. New 
techniques for studying PPIs are needed to gain a holistic view of the physiology of this 
pathogen. Fe-S clusters are ubiquitous cofactors required by many proteins involved in 
diverse biological processes123. The main machinery responsible for the assembly of Fe-S 
clusters is predicted to be essential for the survival of M. tuberculosis34,35,126. However, the 
exact mechanisms of Fe-S cluster assembly in mycobacteria are poorly understood. This 
study aimed to develop a method for the analysis of cytoplasmic complexes in mycobacteria 
and subsequent application of this method for the identification of novel proteins involved 
in Fe-S cluster assembly. Here we use blue native-PAGE and affinity purification followed by 
mass spectrometry (AP-MS) for the analysis of mycobacterial cytosolic protein complexes, 
specifically to identify novel proteins involved in iron-sulphur cluster biogenesis. 
The mycobacterial cell wall consists of three primary macromolecules, namely 
peptidoglycan, arabinogalactan and mycolic acids144–146. These three layers are encased in a 
capsule comprised of proteins and polysaccharides. The arabinan-fused long-carbon-chain 
mycolic acids form a thick, waxy and lipid-dense cell wall147. The complexity of the 
mycobacterial cell envelope therefore makes it difficult to rupture. BN-PAGE was optimised 
for the analysis of cytosolic protein complexes extracted from M. bovis BCG. We compared 
two physical lysis methods routinely used for lysis of mycobacteria, namely bead-beating 
and sonication, to determine their compatibility with BN-PAGE. Bead-beating and sonication 
are relatively harsh cell lysis techniques and result in a significant amount of foaming which 
could lead to protein denaturation resulting in protein loss. These harsh cell lysis techniques 
could also potentially disrupt native complex interactions. Freezing cell pellets prior to lysis 
weakens the cell wall and facilitates more efficient protein extraction. Pre-lysis lysozyme 
treatment could also be used to weaken the cell wall due to its ability to hydrolyse 
polysaccharides in the capsule and break down the peptidoglycan backbone148, thereby 
permeabilizing the mycobacterial cell wall and allowing for less harsh sonication to be used. 
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Due to the complexity of protein samples and the fact that BN-PAGE analysis is a crude, low-
resolution technique, it was difficult to assess the effect of these lysis techniques on the 
integrity of the protein complexes. 
Buffer exchange was performed to assess whether the salt concentration in the 
sample had an effect on BN-PAGE analysis. Although no apparent effect could be observed, 
again, this is difficult to assess due to the low resolution of BN-PAGE, particularly when 
evaluating a very complex sample.  To overcome this limitation, mass spectrometry can be 
used to evaluate the integrity of a well characterised protein complex in response to dialysis 
or different salt concentrations, although this can be costly. Most cell lysis methods result in 
the release of nucleic acids which associate either specifically or non-specifically with 
proteins in the sample. DNA present in protein lysates could result in increased viscosity, 
causing sample streaking during BN-PAGE analysis. This streaking of protein samples during 
electrophoresis could interfere with BN-PAGE analysis and DNA-protein association can also 
interfere with proteomic analysis149. Sonication is a harsh cell lysis technique and 
contributes to the shearing of DNA, but does not remove the entire DNA present in the 
sample. DNase I treatment appeared to eliminate sample streaking, thereby increasing the 
BN-PAGE resolution. Protein precipitation techniques are also commonly used for the 
removal of DNA from protein samples; however, protein precipitation could compromise 
the integrity of complex associations and might not be suitable for BN-PAGE.  
Having optimized cell lysis, we then examined whether we were able to recover 
intact protein complexes. We used the well-characterised RNA polymerase complex for this 
purpose. We demonstrated that protein complexes analysed by BN-PAGE could be 
immunodetected and that protein complexes could be separated into individual 
components by 2D BN/SDS-PAGE, and individual components subsequently 
immunodetected. Four of the six components of the RNA polymerase complex, namely 
RpoA (38 kDa), RpoB (129 kDa), RpoC (147 kDa) and SigA (58 kDa) could be identified by LC-
MS/MS. RpoZ (12 kDa) and SigH (24 kDa) could however not be identified. This is possibly 
due to the fact that these proteins are the smallest proteins in the complex. Smaller 
proteins are less efficiently detected by MS/MS in complex samples since trypsin digestion 
yields fewer peptides and this signal could be masked by the larger proteins in the complex 
that have more peptides liberated after proteolysis. This problem could be overcome by 
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fractionating the complex into its individual components using 2D BN/SDS-PAGE and then 
analysing these components individually by mass spectrometry. It is important to note that 
detection of peptides is also dependent on the ionisation properties of peptides. Many 
other proteins were also identified in the gel fraction. STRING analysis predicted that 41 of 
the 44 proteins identified form part of the same interaction network. It is tempting to 
speculate that these proteins are interacting with components of RNA polymerase, however 
due to the complexity of the sample it is more likely that multiple complexes are present at 
the same position in the gel. Fractionation techniques such as sucrose density gradient 
separation, gel filtration or chromatographic separation could be used to decrease sample 
complexity and decrease possible background. BN-PAGE for the identification of protein 
complexes is therefore best utilised in conjunction with other techniques, such as affinity 
purification, to reduce sample complexity and co-migration of complexes. 
Fe-S cluster-containing proteins can lose their clusters in the presence of oxidative 
and nitrosative stress. Fe-S cluster assembly machinery is then upregulated to compensate 
for this loss150–153. Here we attempted to identify Fe-S cluster assembly proteins by 
upregulation of this complex in response to oxidative and nitrosative stress. We showed 
that no visible difference in banding pattern could be observed after M. bovis BCG exposure 
to oxidative and nitrosative stress and subsequent analysis of cytosolic protein complexes 
by BN-PAGE. Previous studies demonstrating an upregulation of Fe-S cluster assembly 
machinery after exposure to oxidative and nitrosative stress were evaluated at a transcript 
level using qRT-PCR. Our inability to detect induction could be as a result of post-
transcriptional gene regulation. Another major limitation of BN-PAGE is its relatively low 
resolution, making it exceedingly problematic to visualise variation in the banding pattern of 
a complex protein sample. For future work, qRT-PCR should be used as a starting point to 
confirm upregulation of genes of interest on a transcript level. Fractionation techniques 
mentioned above could also be used to decrease sample complexity. High-resolution mass 
spectrometry could then be used to analyse proteins present in these complexes, 
upregulated after exposure to oxidative and nitrosative stress. 
An alternate approach for identifying the Fe-S cluster biogenesis machinery, namely 
immunodetection was then explored. Since no antibodies are available against proteins of 
the SUF machinery, the first step in this approach was to express and purify one of these 
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proteins for antibody generation. We chose to express the cysteine desulphurase, Csd, and 
three fusion tags of different sizes were selected for this purpose. Fusion tags have 
previously been shown to facilitate protein expression by increasing the solubility of fusion 
proteins69,154. However, heterologous expression of Csd in E. coli was unsuccessful. 
Heterologous expression of M. tuberculosis proteins is a common problem possibly due to 
the GC-rich nature of the DNA in this organism, and the differences in codon usage 
compared to that of E. coli. M. tuberculosis utilizes a higher percentage of alanine, proline, 
arginine and glycine compared to E. coli155,156. The machinery responsible for M. tuberculosis 
post-translational modifications is also lacking in E. coli, contributing to the likelihood of M. 
tuberculosis protein aggregation when expressed in E. coli. Heterologous protein expression 
of M. tuberculosis proteins in E. coli is, however, still a favourable approach due to the fast 
growing nature of E. coli and the availability of E. coli expression vectors which facilitate a 
high yield of protein production. Protein expression at low temperatures has been shown to 
improve protein solubility and decrease heat shock protein expression, proteolytic 
degradation and protein aggregation157. Different E. coli strains such as Arctic express or 
expression vectors, such as pCOLD, co-express cold shock proteins which facilitate soluble 
expression of M. tuberculosis proteins155. M. tuberculosis protein solubility can also be 
improved by co-expressing M. tuberculosis chaperone proteins, such as the E. coli GroEL 
ortholog, Cpn60.1158. Co-expression of proteins within the same metabolic pathway has also 
been shown to improve protein expression159–161. In this case, none of these approaches 
proved useful and attempts at antibody generation ended here. 
Due to the above mentioned problems associated with heterologous M. tuberculosis 
protein expression in E. coli, we decided to express Csd and SufC as 6xHis-tag fusions in M. 
smegmatis. These fusion proteins could then be used to detect the Fe-S cluster assembly 
complex using commercial antibodies raised against fusion tags and to purify this complex 
by affinity purification. Expressing M. tuberculosis proteins in a host more closely related to 
this organism, such as the fast growing M. smegmatis, has been shown to be a successful 
alternative for proteins which cannot be solubly expressed in E. coli132,156,163,164. 6xHis-tag 
fusion proteins were expressed under the control of a tetracycline-responsive promoter. 
The tetracycline-responsive expression system was used as protein over-expression can be 
toxic at certain levels and can lead to protein aggregation, promoter mutation and plasmid 
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loss over time165. No change in growth was observed for strains expressing Csd and SufC in 
the presence or absence of atc, indicating that overexpression of these proteins under these 
conditions was not toxic to M. smegmatis. Soluble protein expression was optimised by 
testing different growth stages and different atc concentrations. 
The fusion proteins were then used to enrich for the Fe-S cluster assembly 
machinery under native conditions using a nickel IMAC resin. Affinity purification was 
optimised by evaluating different volumes of nickel beads and different salt concentrations. 
No difference in Csd recovery was seen between the 60 µl and 100 µl Ni-particle samples for 
the low salt supernatant fraction, even though a significant proportion of residual Csd could 
still be detected. This indicates that a proportion of Csd does not bind to the Ni-particles 
under near-physiological salt concentrations, most likely due to the inaccessibility of the 
6xHis-tag under native complex conditions. Larger affinity fusion tags could be explored in 
an attempt to remedy this problem, although, this could potentially interfere with the 
native complex structure. A protein’s structure strongly influences its interaction potential. 
Protein surface chemistry is incredibly complex and interactions between proteins occur as 
a result of hydrogen bonding, electrostatic, ionic, hydrophobic and van der Waals 
forces166,167. The direct effect of salt concentration on these forces is poorly understood. 
Sodium chloride is a chaotropic salt which disrupts the stability of intramolecular forces 
responsible for protein-protein interactions. High salt concentrations are commonly used in 
affinity purification protocols to limit the amount of non-specific protein interaction with 
the proteins of interest and the resin used. However, high salt concentrations weaken the 
stability of native protein complexes. Near-physiological salt concentrations are therefore 
more suitable when enriching for native protein complexes.  
In order to identify the Fe-S cluster assembly complex, Csd and SufC fusions were 
used to isolate this complex by affinity purification and subsequently analyse enriched 
protein samples by high-resolution mass spectrometry.  Exploratory data analysis revealed 
that the technique was reproducible and that protein level differences existed that could be 
used to discriminate between affinity purifications using different bait proteins. Enzymes 
identified by SufC affinity purification accounted for the bulk of the identified proteins. SufC 
forms part of the Fe-S cluster assembly scaffold and interacts stably with the other scaffold 
proteins, namely SufD and SufB. SufC is an ATPase and displays homology to ATPase 
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subunits of membrane transporters although SufC is found in the cytosol168. SufC is required 
for in vivo assembly of Fe-S clusters and has been implicated in iron acquisition rather than 
sulphur transfer. SufC is also thought to stabilize SufB for Fe-S cluster formation on SufB. 
SufC occurs as a homodimer and was found to be associated with itself in our dataset, along 
with other known interactors, namely Csd, SufB and SufD. A DNA-binding protein that 
shares homology with Rv1460 transcriptional regulator was also present in the SufC affinity 
enrichment. Other ATPases were also present in the SufC affinity enrichment, such as RadA, 
a DNA repair protein, and MSMEG_5014, involved in copper translocation. This suggests 
that the ATPase activity function of SufC might not be limited to Fe-S cluster assembly. 
A cysteine desulphurase is required for the first step of Fe-S cluster assembly, which 
catalyses the transfer of sulphur from L-cysteine to a scaffold protein123,124. In addition to 
the cysteine desulphurase present in the suf operon (csd), the genome of M. tuberculosis 
also encodes 2 other genes with homology to this enzyme, namely iscS, and egtE 
(Rv3700c)130,169. IscS does not interact with any of the proteins in the SUF system, but 
interacts with Fe-S cluster-containing proteins. Deletion of iscS in M. tuberculosis resulted in 
impaired activity of enzymes containing Fe-S clusters, suggesting that IscS is involved in Fe-S 
cluster assembly38. egtE encodes a pyridoxal-phosphate-dependent protein which probably 
catalyses the conversion of hercynylcysteine sulfoxide to ergothioneine. Ergothioneine is an 
antioxidant secreted by mycobacteria and is involved in protection against oxidative 
stress37. The relationship between these 3 cysteine desulphurases is unknown. Csd interacts 
transiently with the scaffold and functions as the sulphur donor. It was therefore 
hypothesised that Csd may function promiscuously as a sulphur donor in interaction with 
other complexes which require sulphur; however, this did not appear to be the case. 
Proteins responsible for the biosynthesis of other sulphur-containing molecules which 
require cysteine desulphurases such as molybdenum cofactor, mycothiol and ergothionine 
were lacking in our analysis, suggesting that Csd might be a Fe-S cluster-specific sulphur 
donor.  
The association between SufC and known or potential Fe-S cluster containing 
enzymes suggests a direct interaction between the scaffold and apo-proteins for Fe-S cluster 
insertion. This would contrast the hypothesis of A-type carrier-mediated Fe-S cluster 
transfer from the scaffold to apo-proteins, but would be consistent with the hypothesis of 
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direct cluster transfer from scaffold to apo-protein. A-type carrier-mediated Fe-S cluster 
transfer is well defined in E. coli, and is shown to be essential for the maturation of certain 
Fe-S cluster-containing proteins170. It is currently unknown if carrier proteins are required 
for Fe-S cluster transfer in mycobacteria. There is also evidence in E. coli for direct Fe-S 
cluster transfer from the scaffold to the apoproteins170. A similar scenario has been 
suggested for the IscS of M. tuberculosis. IscS was shown to interact directly with Fe-S 
cluster containing proteins, although no interaction with the SUF machinery was observed38. 
IscS was also shown to be sufficient for the assembly of the Fe-S cluster in WhiB3, a 
transcriptional regulator130. Proteins that map to biological processes related to protein 
synthesis and transcriptional regulation were largely overrepresented in association with 
Csd and SufC. The close proximity of Fe-S cluster assembly proteins and proteins involved in 
protein synthesis suggest that Fe-S clusters could possibly be inserted as proteins are being 
synthesized. A similar phenomenon is observed in the molybdenum cofactor biosynthesis 
pathway where molybdenum cofactor is rapidly acquired by molybdenum-dependent 
enzymes during the early stages of maturation171. 
Ferrous iron is essential to the survival of most living organisms, but can be toxic at 
high levels due to Fenton reactions172,173. Iron acquisition and storage should therefore be 
tightly regulated. The iron donor for Fe-S cluster assembly is currently unknown174,175. 
Frataxin has been proposed as the iron donor in eukaryotes176,177 and its homolog, CyaY, 
proposed for iron donation in the bacterial ISC system174. Due to the fact that the SUF 
system is functional under iron limited conditions, it has been suggested that the SUF 
system acts as an “iron trap”, using iron binding proteins, called ferritins, for the storage of 
iron178. In mycobacteria iron is acquired from the environment by siderophores. It is 
suggested that iron-binding carriers transport iron to where it is needed in the cell. In 
Erwinia chrysanthemi, the SUF system has been implicated in the transfer of iron to 
bacterioferritin where it is stored until incorporation into apo-proteins is required178. Metal 
ion binding proteins and proteins involved in metal ion transport, such as the divalent metal 
cation transporter identified in association with Csd, MntH, represents an interesting cohort 
of proteins to investigate as they may play a direct role in Fe-S cluster assembly by providing 
Fe2+ or by regulating Fe-S cluster assembly or repair.     
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mCherry did not serve as an appropriate control as known interactors of Csd and SufC, such 
as SufB and SufD which form part of the scaffold were also identified in the control. Non-
specific protein association with mCherry makes eliminating background challenging. This 
non-specific association with mCherry also lead to much difficulty in choosing an 
appropriate stringency when filtering for proteins that are likely to interact with highest 
confidence. It is for this reason that 2 levels of stringency were used. Many interacting 
partners may have been eliminated due to non-specifically associating with mCherry and 
the criteria used for high stringency filtering. Choosing an appropriate control for affinity 
purification techniques of this nature is challenging as one would need to find an unrelated 
protein that is known not to interact with any of the components of the complex of interest, 
however this is difficult to predict and can often only be determined empirically. 
Although a M. smegmatis groEL1ΔC carrying a deletion of the histidine-rich C-
terminus in GroEL1 was used for affinity purification, non-specific co-purification of GroEL1 
and associated proteins were still present in relatively high abundance. Due to the high 
abundance of GroEL in mycobacteria, its important function in protein folding, and high-
background associated with affinity purification techniques, this was not surprising. This is, 
however, problematic for protein identification by mass spectrometry as higher abundant 
proteins can mask the signal of proteins with occurs in low abundance, and true interactions 
could be masked. 
Approximately 50 genes encoding putative Fe-S cluster containing proteins in M. 
tuberculosis were previously predicted by using bioinformatics-based amino acid pattern 
searches and literature curation179. The M. smegmatis homologs of these proteins are 
lacking in our dataset. This could be due to inaccurate prediction or alternative mechanisms 
of Fe-S cluster insertion, such as carrier protein-mediated Fe-S cluster insertion. Another 
theory is that the cysteine desulphurase, IscS, the housekeeping Fe-S cluster biogenesis 
sulphur donor in E. coli, could be responsible for direct Fe-S cluster insertion without the 
need for interaction with the SUF machinery38. Many factors influence which interactions 
are identified, including the stage of bacterial growth at which sampling took place, whether 
or not interactions are stable or transient and the environmental condition in which 
interactions take place. Certain growth stages and environmental conditions could be 
favourable for certain interactions and unfavourable for others.  
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5.2. Future work and concluding remarks 
The work done in this study serves only as an initial screen and possible interacting 
proteins identified by mass spectrometry in association with Csd and SufC need to be 
validated using other techniques for detecting protein-protein interactions, such as yeast 
two-hybrid, protein complementation assays or co-immunoprecipitation. Once interactors 
have been confirmed, their role in Fe-S cluster biogenesis would need to be established. 
One approach would be to generate deletion mutants of confirmed non-essential 
interactors and to evaluate the effect on Fe-S cluster biogenesis. Direct measurement of Fe-
S cluster abundance is not possible due to cluster instability. Fe-S cluster-dependent enzyme 
activity is therefore used as an indirect measurement of Fe-S cluster formation. This method 
is well defined, using succinate dehydrogenase and aconitase for enzyme activity assays180.  
An alternate approach for interacting partners predicted to be essential in 
mycobacteria, would be the generation of conditional mutants. Recently, the generation of 
conditional mutants in mycobacteria by protein depletion was described and appears to be 
more effective than previous methods181,182. This work could be expanded by using binary 
protein-protein interaction techniques in order to define specific interactions occurring 
within the Fe-S cluster assembly complex. Soluble expression and purification of Fe-S cluster 
complex components will allow these interactions to be characterised by in vitro 
biochemical assays. A technique has recently been developed which is based on the fusion 
of potential Fe-S cluster-containing proteins to a fluorescent probe which can be used to 
track the transfer of Fe-S clusters between proteins183. Although this methodology is still in 
its infancy, it provides an interesting approach for monitoring Fe-S cluster kinetics by 
tracking Fe-S cluster flux through different branch points within transfer pathways.  
Proteomic analysis of multiprotein complexes is possibly one of the most challenging 
and daunting techniques of modern day molecular biology due to the overwhelming 
complexity of the proteome. Few methods for achieving this task are available. The lack of 
specific antibodies against the Fe-S cluster biogenesis machinery, which could be used for 
immunodetection and affinity purification, limits the application of these techniques. 
Antibody generation is costly and labour intensive. The use of affinity tag protein fusions 
provides a feasible solution to this problem; however, non-specific protein interactions with 
affinity tags and their relevant resins are common. Using affinity purification together with 
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BN-PAGE, 2D BN/SDS-PAGE and fractionation techniques would be an efficient and sensitive 
approach for identifying physiologically relevant protein-protein interactions. For a more 
comprehensive understanding of the mycobacterial Fe-S cluster interaction network, AP-MS 
analysis should be evaluated at different stages of growth and under different 
environmental conditions. This work is an important starting point for elucidating the 
complete Fe-S cluster biogenesis interaction network in mycobacteria. 
 
  




A.1. Plasmid maps 
 
Figure A.1. pET-28a(+) plasmid map (Novagen). 




 Figure A.2. pGEX-6P-1 vector map (GE Healthcare Life Sciences). 




Figure A.3. pMAL-c5X vector map (New England Biolabs). 
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Table A.1. Proteins identified by mass spectrometry from the RNA polymerase gel spot excised from BN-PAGE  










1,3-propanediol dehydrogenase activity; 
alcohol dehydrogenase (NAD) activity; metal 
ion binding 
  2   
A0R2B1 kgd, sucA, 
MSMEG_5049, 
MSMEI_4922 
2-hydroxy-3-oxoadipate synthase activity; 2-
oxoglutarate decarboxylase activity; 
dihydrolipoyllysine-residue 
succinyltransferase activity; metal ion 
binding; oxoglutarate dehydrogenase 
(succinyl-transferring) activity; thiamine 
pyrophosphate binding 
tricarboxylic acid cycle 7 4 
A0R171 MSMEG_4646, 
MSMEI_4528 
2-oxoglutarate synthase activity   3 2 
A0QVQ5 pnp, gpsI, 
MSMEG_2656, 
MSMEI_2593 
3'-5'-exoribonuclease activity; magnesium 
ion binding; polyribonucleotide 
nucleotidyltransferase activity; RNA binding 
mRNA catabolic process; RNA processing 6 3 
A0R0B3 acpM, MSMEG_4326, 
MSMEI_4226 
ACP phosphopantetheine attachment site 
binding involved in fatty acid biosynthetic 
process 
  2   
A0QWS1 pyrB, MSMEG_3043, 
MSMEI_2969 
amino acid binding; aspartate 
carbamoyltransferase activity 
de novo' pyrimidine nucleobase biosynthetic 
process; 'de novo' UMP biosynthetic process; 
cellular amino acid metabolic process 
2   
A0R4G8 apeB, MSMEG_5828, 
MSMEI_5670 
aminopeptidase activity; metallopeptidase 
activity; zinc ion binding 
  2   
A0QTV4 groL, MSMEG_1978, 
MSMEI_1934 
ATP binding protein refolding 2   
A0QQC8 dnaK, MSMEG_0709, 
MSMEI_0692 
ATP binding protein folding 2   
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A0QQU5 groL1, groEL1, 
MSMEG_0880, 
MSMEI_0859 
ATP binding  protein refolding 5 9 
A0QV14 pyc, pca, 
MSMEG_2412, 
MSMEI_2351 
ATP binding; biotin binding; biotin 
carboxylase activity; metal ion binding; 
pyruvate carboxylase activity 
gluconeogenesis; pyruvate metabolic process 2 4 
A0QTE1 accA3, MSMEG_1807, 
MSMEI_1762 
ATP binding; biotin carboxylase activity; 
metal ion binding 
  4   
A0QV25 smc, MSMEG_2423, 
MSMEI_2362 
ATP binding; DNA binding chromosome condensation; DNA replication; 
sister chromatid cohesion 
  3 
P48354 gyrA, MSMEG_0006, 
MSMEI_0008 
ATP binding; DNA binding; DNA 
topoisomerase type II (ATP-hydrolyzing) 
activity 
DNA-dependent DNA replication; DNA 
topological change; response to antibiotic 
9 5 
A0QNE0 gyrB, MSMEG_0005, 
MSMEI_0007 
ATP binding; DNA binding; DNA 
topoisomerase type II (ATP-hydrolyzing) 
activity; magnesium ion binding 
DNA-dependent DNA replication; DNA 
topological change 
6 5 
A0R079 glnA, glnA1, 
MSMEG_4290, 
MSMEI_4189 
ATP binding; glutamate-ammonia ligase 
activity 
glutamine biosynthetic process; nitrogen 
fixation 
9 11 
A0R218 rho, MSMEG_4954 ATP binding; helicase activity; RNA binding; 
RNA-dependent ATPase activity 
DNA-templated transcription, termination 5 4 
A0R143 nadE, MSMEG_4617, 
MSMEI_4500 
ATP binding; hydrolase activity, acting on 
carbon-nitrogen (but not peptide) bonds; 
NAD+ synthase (glutamine-hydrolyzing) 
activity 
NAD biosynthetic process   3 
A0R200 atpD, MSMEG_4936, 
MSMEI_4809 
ATP binding; proton-transporting ATP 
synthase activity, rotational mechanism 
ATP hydrolysis coupled proton transport; 
plasma membrane ATP synthesis coupled 
proton transport 
2 3 
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A0R196 clpX, MSMEG_4671, 
MSMEI_4553 
ATP binding; zinc ion binding protein folding 2   
A0QYW4 uvrA, MSMEG_3808, 
MSMEI_3720 
ATPase activity; ATP binding; DNA binding; 
excinuclease ABC activity; zinc ion binding 
nucleotide-excision repair; SOS response 2   




  5 5 
A0R5H1 MSMEG_6189, 
MSMEI_6029 
DNA binding regulation of transcription, DNA-templated; 
transcription, DNA-templated 
2 2 
A0QSL8 rpoA, MSMEG_1524, 
MSMEI_1488 
DNA binding; DNA-directed RNA polymerase 
activity 
transcription, DNA-templated 9 12 
A0QS66 rpoC, MSMEG_1368, 
MSMEI_1329 
DNA binding; DNA-directed RNA polymerase 
activity 
transcription, DNA-templated 19 25 
P60281 rpoB, MSMEG_1367, 
MSMEI_1328 
DNA binding; DNA-directed RNA polymerase 
activity; ribonucleoside binding 
response to antibiotic; transcription, DNA-
templated 
16 29 
A0QW02 rpoD, sigA, 
MSMEG_2758, 
MSMEI_2690 
DNA binding; sigma factor activity; 
transcription factor activity, sequence-
specific DNA binding 
transcription initiation from bacterial-type RNA 
polymerase promoter 
4 2 
A0R025 mraZ, MSMEG_4236, 
MSMEI_4136 
DNA binding; transcription factor activity, 
sequence-specific DNA binding 





fatty acid biosynthetic process 11 10 
A0R2T4 xseA, MSMEG_5226 exodeoxyribonuclease VII activity; nucleic 
acid binding 
DNA catabolic process 2 2 
A0R1C2 gdh, MSMEG_4699, 
MSMEI_4582 
glutamate dehydrogenase (NAD+) activity glutamate catabolic process to 2-oxoglutarate 5 4 
A0QS98 tuf, MSMEG_1401, 
MSMEI_1363 
GTPase activity; GTP binding; translation 
elongation factor activity 
  2 2 
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I7FJV9 infB, MSMEI_2565 GTPase activity; GTP binding; translation 
initiation factor activity 
  4 2 
A0R617 MSMEG_6392 hydrolase activity, acting on ester bonds; 
phosphopantetheine binding; transferase 
activity 
biosynthetic process 2 4 
A0QSU3 guaB, MSMEG_1602 IMP dehydrogenase activity purine nucleotide biosynthetic process 7 3 
A0QYL9 aceA, aceAb, 
MSMEG_3706, 
MSMEI_3618 
isocitrate lyase activity carboxylic acid metabolic process 9 10 
A0R3B8 eno, MSMEG_5415, 
MSMEI_5267 
magnesium ion binding; phosphopyruvate 
hydratase activity 
glycolytic process 5 4 
A0QYY6 rpsA, MSMEG_3833, 
MSMEI_3743, 
LJ00_19040 
nucleotidyltransferase activity; RNA binding; 
structural constituent of ribosome 
translation 2 2 
A0R616 accD4, MSMEG_6391, 
MSMEI_6223 
propionyl-CoA carboxylase activity   2   
A0QTE7 accD5, MSMEG_1813, 
MSMEI_1769 
propionyl-CoA carboxylase activity   5 2 
A0R3J2 pccB-1, MSMEG_5492, 
MSMEI_5340 
propionyl-CoA carboxylase activity; 
transferase activity 
  3   
A0QSG6 rpsE, MSMEG_1472, 
MSMEI_1436 
rRNA binding; structural constituent of 
ribosome 
translation 3   
A0QSD4 rplB, MSMEG_1439, 
MSMEI_1403 
rRNA binding; structural constituent of 
ribosome; transferase activity 
translation 2 2 
A0QZ46 prcA, MSMEG_3894, 
MSMEI_3804 
threonine-type endopeptidase activity modification-dependent protein catabolic 
process; proteasomal protein catabolic process 
2   
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